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Abstract

Nathan Paul Spangenberg
THE IMPACT OF PATIENT-SPECIFIC VASCULAR STRUCTURE ON LOCALIZED
COOLING IN THE HUMAN HEART
2017-2018
Thomas L. Merrill, Ph.D.
Master of Science in Mechanical Engineering
Acute Myocardial Infarction (AMI) is the leading cause of worldwide death and
disability, and approximately 720,000 Americans will experience an AMI in 2018. Studies
have shown that rapid hypothermia therapy (< 35°C) before reperfusion in patients with
AMI can reduce infarct size by 37%. Localized therapeutic hypothermia has proven the
potential to cool heart tissue rapidly following AMI, 3°C in 5 minutes. Using Materialise
Mimics digital imaging software and the finite volume method we analyzed temperature
distributions in six patient-specific left main coronary artery (LMCA) models. A mock
circulatory loop was used to determine the exiting temperatures of a standard 7 Fr catheter
to feed into our model with flow rates ranging from 29.2 ml/min to 68.85 ml/min. Our work
showed that therapeutic hypothermia (TH) temperatures were evident at the outlets of three
out of all six heart models, which varied in each left anterior descending (LAD) and left
circumflex (LCX) artery depending on flowrate. Results of this study indicate that
biovariability in patient-specific vascular structures significantly impacts therapeutic
hypothermia (TH) treatment methods. These results indicate that further research is needed
to examine more accurate physiological effects, such as pulsatile flow and vessel wall
thickness. Future models will be used to provide insight to guide more efficient TH device
designs and operation parameters to optimize patient outcomes following AMI.
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Chapter 1
Introduction
Basic Physiology of the Human Heart
The human heart is an organ made of muscle that is responsible for pumping
blood to the rest of the body and to itself via the aorta [1][2]. The heart consists of two
atria and two ventricle chambers (Fig. 1.1) where de-oxygenated blood enters the right
atrium via the superior vena cava.

Figure 1.1. Basic cardiac circulation of the human heart. The right side of the heart
supplies blood to pulmonary circulation, while the left side of the heart supplies blood to
systemic circulation [3].

The right atrium contracts and blood is pumped into the right ventricle. When the
left ventricle contracts, deoxygenated blood is pumped to the lungs through the
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pulmonary artery. In the lungs, blood releases carbon dioxide and loads up with oxygen.
Oxygenated blood flows back into the left atrium, is pumped into the left ventricle, and
then expelled into the aorta to sustain circulation.
The circulatory system consists of the heart, blood, and blood vessels, and
circulates an average of 5 liters of blood throughout the human body [2]. Diastolic blood
flow refers to the relaxation of the atrial and ventricle chambers. Systolic blood flow
refers to the contraction of the atria and ventricle chambers. These contractions are
initiated by action potentials from electrical excitatory impulses, however, the
electrophysiology of the heart is beyond the scope of this work.
Vascular networks. After blood is pumped into the aorta, it enters the left and
right coronary arteries to provide oxygen and nutrients to the myocardium (heart muscle)
[2]. The left main coronary artery (LMCA), which originates from the proximal aortic
arch, supplies blood to the left myocardium and bifurcates into the left anterior
descending artery (LAD) and the left circumflex artery (LCX) [4]. The LAD supplies
blood to the front of the heart, while the LCX circles the left myocardium and supplies
blood to the back of the heart. The oblique LAD and LCX networks bifurcate into many
daughter branches (Fig. 1.2) that span the surface of the heart.
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Figure 1.2. Image of the LMCA bifurcating into the LAD and LCX arteries that each
branch into daughter vessels producing patient-specific artery networks. Each person has
a unique coronary vascular network with arteries varying in length, diameter, and
location of bifurcated branches [5]. This work will explore organ cooling along these
vessels.

For the LAD, these branches consist of the 1st septal perforator, 1st and 2nd diagonal, and
the proximal, mid, and distal branches [5]. For the LCX, these branches consist of the
atrial, obtuse marginal, and the posterior lateral branches. For this work, extensive
research was performed to assess and determine appropriate LMCA geometries [6][7][8],
native coronary flow rates [9]–[12], and catheter infusate flow rates for intracoronary
procedures [13][14].
Coronary flow rates. Coronary flow rates have been measured in clinical settings
using intracoronary doppler and ultrasound [11], phase contrast MRI video measurements
[12], intracoronary frequency domain optical coherence tomography [15], and methods
using doppler wires [16]. Using these methods, coronary flow rates ranged between 29.7
ml/min and 107 ml/min in the LAD and 28.4 ml/min and 112 ml/min in the LCX
[9][10][11][12]. Typical blood flow rates in the cardiac cycle (Fig 1.3) entering the left
coronary artery network are pulsatile in nature and consists of the systole ejection phase
and the diastole phase [17].
3
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Figure 1.3. The cardiac cycle for blood flow entering the left coronary artery [17]. The
typical cardiac cycle is pulsatile in nature and consists of the systole ejection phase (SEP)
and the diastole phase (DP), which represents the time between 0.3s to 0.5s and 0.5s to
the beginning of the SEP cycle, respectively.

Variations between patients. Coronary artery geometry variations between
patients affect nearly 5.6% of Americans, and include varying bifurcation patterns, vessel
lengths and diameters, and dominant/co-dominant LAD and LCX networks [18].
Branching patterns in LMCA networks between patients include high variations of
bifurcations and trifurcations, and if misdiagnosed, could cause difficulties in
catheterization surgeries [19].
Coronary artery anomalies are defects in the geometry of the coronary arteries and
are linked to an abnormal size or varying origin location from the aortic arch. These
coronary artery anomalies between patients vary between 0.2% to 8.4% [20], and have
been associated with congenital heart disease and approximately 15% of young athletes
that experience sudden death [20][21]. Determining geometry patterns and variations in
the coronary arteries is important for physicians to competently treat and diagnose
cardiovascular disease.
4

Acute Myocardial Infarction (AMI)
With the geometry and blood flow described, this research focuses on a common
problem: acute myocardial infarction. Coagulation of inflammatory cells and calcium
deposits may form on the inner walls of the coronary arteries, known as atherosclerotic
plaque [22]. This plaque could rupture and form a clot (thrombus) to reduce blood flow
or could form a complete blockage in the coronary arteries. This phenomenon can lead to
insufficient nutrients and oxygen in the myocardium and is known as myocardial
ischemia. If left untreated, the ischemia region can cause irreversible damage to the
myocardium. This condition is known as acute myocardial infarction (AMI) [23].
Acute Myocardial Infarction (AMI) occurs when metabolically insufficient blood
flows to the myocardium, resulting in cell death (necrosis) [23][24]. AMI is a primary
cause of worldwide death and disability [23][25]. In contrast, AMI incidences have
significantly declined over the past decade, however, it is estimated that 720,000
Americans will experience a new AMI and 335,000 will have a recurrent event in 2018
[26].
Permanent damage to the myocardium can result from AMI. While unresponsive
to contractile function, fibrous scar tissue (infarct area) distal to a blocked artery
(occlusion site) can form (Fig. 1.4) and cause impairment to left ventricular (LV)
contraction, resulting in progressive chronic heart failure [23][24][13].
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Figure 1.4. Schematic of left anterior descending artery occluded with plaque
build-up. Purple area distal to occluded artery represents myocardial area at risk
of infarction [27]. Therapeutic hypothermia is a promising treatment option that
may reduce tissue damage and improve patient outcomes.

Additionally, patients who have experienced an AMI are at risk of a 10% fatality
rate during hospitalization, and a 76% chance of developing chronic heart failure during
the next 5 years [28][29][30][31].
Ischemia Reperfusion Injury
AMI is currently treated by methods of reperfusion, which aim to quickly restore
blood flow to the oxygen-deprived myocardium. Reperfusion is the primary therapeutic
goal for the treatment of AMI and has been shown to restrict the severity of infarction
and even reduce mortality [24][25][26]. Paradoxically, clinical data has shown that
significant myocardium damage can occur from blood reperfusion, accounting for up to
25 to 50% of the resulting myocardial infarct size [32][33]. This is known as ischemia
reperfusion (IR) injury [24][33]. After the occlusion has been removed, the patient is at
risk of both temporal and permanent myocardial injury. The former can span 48 hours to
several days, while the later refers to permanent necrosis of myocardial cells after
6

reperfusion [34][35]. There is currently no active therapy that prevents myocardial
reperfusion injury in patients experiencing an AMI [28]. Most animal and human pilot
studies have shown positive results, but a randomized controlled trial failed to replicate
the outcomes [36].
To improve patient outcomes, new therapeutic strategies are being investigated to
reduce permanent damage caused by IR injury. One therapeutic strategy is known as
post-conditioning and is performed using a balloon catheter that opens an occluded artery
and alters reperfusion mechanically. Moreover, this thesis work will focus on a novel
cardioprotective strategy using therapeutic hypothermia [13][37][38][39][40].
Existing treatments. Several clinical trials have failed to show that drug therapy
can reduce infarct size by limiting reperfusion injury [24][41][42]. Examples of failed
clinical trials for reducing reperfusion injury and reducing myocardial salvage include the
use of Adenosine [43] and inhaled nitric acid [36]. Future efforts that aim to prevent
reperfusion injury or salvage ischemia myocardium should focus on non-pharmacological
approaches as well [43]. An example of a widely used non-pharmacological intervention
procedure to treat AMI is known as percutaneous transluminal coronary angioplasty
(PTCA).
Applied using percutaneous transluminal coronary angioplasty (PTCA). In
September of 1977, Andreas Grüntzig introduced and performed the first minimally
invasive percutaneous transluminal coronary angioplasty (PTCA) in a patient. PTCA has
since become the most widely used major intervention procedure to treat patients with
angina and AMI [44][45]. PTCA offers a non-surgical treatment method for intervention
in AMI, a primary source of mortality in western Europe and North America, and has
recently improved its success rate since the introduction of stenting [46][47][48].
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Timely use of revascularization procedures, or reperfusion to an organ or body
part suffering ischemia, has shown to contribute to decreased mortality rates in patients
who have undergone percutaneous coronary interventions (PCI) in ST-segment elevation
myocardial infarctions (STEMI) [49]. As of 2009, median costs for PCI procedures
(including intervention procedure and hospitalization) were $19,349 [50].
Treatment to reestablish sufficient coronary blood flow after AMI using primary
percutaneous coronary intervention (P-PCI) is performed using balloon angioplasty (Fig
1.5), with or without stenting [25].

a.

b.

c.

d.

Figure 1.5. Primary percutaneous coronary intervention (P-PCI) performed using balloon
angioplasty with stenting [51]. The occlusion is located in the artery network (a) and a
guide is advanced through the femoral artery into the occluded vessel with the balloon
and stent (b). The balloon is inflated (c) to expand the stent (d) and open the occluded
vessel [25].

These devices for treating AMI are designed to be used in emergency cardiac
catheterization laboratories. Stents used are either bare-metal stents (BMS) or drugeluting stents (DES) [52]. Of these, Cobalt chromium DES’s exhibit the most favorable
outcome to reduce AMI, stent thrombosis, and cardiac death rate [25].
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Additionally, the use of post-conditioning (PC) is a moderately new
revascularization procedure which is used to diminish IR injury by inducing transitory
cycles of ischemia during the onset of reperfusion [53]. During this procedure, a PTCA
balloon catheter is inserted into the femoral artery and advanced proximally to the
occluded artery and is intermittently inflated and deflated per a predetermined algorithm.
Although coupled with PTCA and PC procedures, external cooling blankets can result in
side effects including increased infection risk, wound healing degradation, and patient
discomfort from shivering due to unintentional overcooling [54][55].
Other treatments. Percutaneous transluminal coronary interventions (PTCI) have
proven to be effective methods at improving heart function and diminishing the size of
myocardial infarct [56]. However, clinical trials involving the use of PTCI with
adjunctive therapies have failed to show positive results following myocardial infarction
(MI) [57][58]. Other MI preventative treatments involve prescribing patients with
antiplatelet P2Y12-receptor blockers prior to angioplasty procedures, which act to reduce
vessel obstruction post PCI [56]. Still, clinical trials involving platelet inhibitors
combined with PCI have failed to report positive results with PC [59][60]. MI outcomes
will not be improved unless cardioprotective therapies surpass the effects of antiplatelet
agents. Other treatment methods suggest the use of mild hypothermia coupled with
sodium-hydrogen blockers that have helped to reduce infarction in rats when used with
P2Y12 inhibitors [61]. A suggested solution to reducing MI is the development of an
intervention that induces rapid cooling with platelet inhibitors during the time of
reperfusion [56].
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Therapeutic Hypothermia
Therapeutic Hypothermia (TH) aims to reduce normal tissue temperatures to
improve patient outcomes [62][63][64].
History. Ancient Egyptian, Roman, and Greek physicians used hypothermia to
treat humans with trauma and hemorrhage [65][66], and was even used in 400 BC by
Hippocrates who advised the use of snow and ice on wounded patients to reduce
hemorrhage and bleeding [67]. TH was reintroduced in the 1940s to 1960s as a method to
treat cardiac arrest patients [68][69][70], and was used as an effective method for organ
transplantation, which was thereafter considered routine postoperative care [71][72].
Aside from the hospital, hypothermia has been used to salvage the brain in animals and
humans succeeding cardiac arrest [63][64]. Hypothermia is recommended by the
American Heart Association and the European Resuscitation Council to improve
neurological recovery in comatose patients that have experienced a cardiac arrest [73].
Hypothermia can be categorized as mild, moderate, severe, or profound, with
temperatures ranging between 32-35 °C, 28-32°C, 20-28°C, and <20°C, respectively
[74]. TH is mostly attributed to mild hypothermia due to its hemodynamic stability in
animals and humans. Moderate hypothermia could induce atrial fibrillation, while severe
hypothermia could induce ventricular fibrillation [74][75][76]. To effectively reduce
infarct size and safely diminish reperfusion injury, myocardial temperatures should be
between 32-34°C [13][77][78].
Existing treatments. Current TH treatment methods consist of methods using
external cooling blankets, percutaneous transluminal coronary angioplasty, and
endovascular whole-body devices that require a separate insertion into the inferior vena
cava.
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External cooling blankets. Non-invasive technologies are also under
development. A non-invasive surface cooling apparatus called ThermoSuit has been
tested on animals to treat early phase AMI via whole body cooling. However, along with
similar noninvasive cooling blanket techniques, it remains a challenge to effectively cool
patients at a cooling rate of 3.0°C/hour without causing adverse-effects such as frequent
wound infections and disturbed shivering [79][80][81]. Moreover, US domestic hospitals
have lethargically implemented the use of TH in their cases involving postcardiac arrest
patients [82]. This is considered partially a result of TH unfamiliarity amongst physicians
and the inaccuracy of external cooling using blankets and ice bags, which are usually
inaccurate at maintaining TH temperatures [83].
Endovascular whole-body devices. Patients undergoing endovascular whole-body
cooling interventions to treat AMI experience whole-body hypothermia at 33⁰ C [13].
These procedures typically require a separate insertion in the femoral vein (Fig. 1.6) for
the delivery of a cooling device to be positioned in the Inferior Vena Cava (IVC) [84].
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Chilled Saline Out
Chilled Saline In
Figure 1.6. Endovascular cooling device inserted in the femoral vein and positioned in the
Inferior Vena Cava (IVC). Patients undergoing endovascular cooling interventions
experience whole-body hypothermia at 33⁰ C [13]. Endovascular cooling methods
maintain target TH temperatures more efficiently than conventional external cooling but
are unable to reach TH temperatures quicker [54].

Target temperatures of TH can be maintained more efficiently using endovascular
cooling methods compared with conventional external cooling blankets [54]. Safety
outcomes between endovascular and external cooling procedures are considered
comparable, while endovascular cooling provides superior accuracy in sustaining TH
target temperatures [85][86]. In comparison, endovascular whole-body cooling devices
may maintain more accurate target temperatures but are unable to reach these
temperatures quicker than conventional external cooling.
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Emerging treatments. Safe, rapid cooling of the heart is an important goal for
physicians to effectively treat patients with AMI. Studies have shown that rapid
hypothermia therapy (< 35°C) before reperfusion in patients with AMI can reduce infarct
size by 37% [87][88][89][90]. This is known as Therapeutic Hypothermia (TH), which
has shown feasibility for cardioprotection via methods of intravenous saline infusion and
endovascular cooling [87][91]. The vast majority of AMI treatment methods involve
whole-body cooling interventions, rather than heart-specific TH cooling devices, which
are currently not on the market [92].
Localized therapeutic hypothermia. Studies have demonstrated the use of
minimally invasive cooling catheters (Fig. 1.7) designed to locally induce TH by
continuously delivering cooled fluids into the infarcted artery [92].

Guide Catheter
GuideLiner®

Figure 1.7. (a) 3D representation of the left anterior descending artery modeled in
Mimics from DICOM HH63 (HH = Human Heart) from the Visible Heart Lab,
University of Minnesota. (b) Schematic illustration of a standard guide catheter
delivering cooled saline into left coronary artery via femoral artery access.
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Localized hypothermia has the potential to cool heart tissue rapidly following
AMI, 3°C in 5 mins without the adverse-effects [93][94]. Nevertheless, the effectiveness
of TH treatment for AMI, measured by myocardial salvage, will be impacted by the
vascular structure with each patient (i.e. bifurcation patterns and vessel lengths and
diameters). That vascular structure is akin to the internal design of an evaporator or a
condenser, where each system, and analogously, each person is different.
Studies performed by Otterspoor [13] studied the impact of intracoronary
hypothermia in patients with acute myocardial infarction. During the occlusion phase, 20
ml/min infusate was delivered at room temperature (22℃) proximal to the occlusion and
the flow rate was adjusted to match a distal coronary artery temperature of 6℃ below
body temperature. During the reperfusion phase (after occlusion removal), saline was
infused at 16 ml/min at 4℃. Out of the ten patients enrolled in the study, six patients had
occlusions in their LAD, one had an occlusion in the LCX, and three had an occlusion in
the RCA.
Another study employed 73 patients, where 53 experienced stable angina (SA)
and 20 had signs of ST-elevation myocardial infarction (STEMI) [95]. Guide catheter
infusions delivered saline at room temperature at 10-30 ml/min flow rates in the LAD and
LCX arteries. The infusion catheter tip was fixed proximal to the occlusion and infusate
was delivered at -5℃ below body temperature in the distal arteries.
In a study performed by McGarvey [96], ten patients experiencing STEMI
endured primary angioplasty (PPCI) by receiving intracoronary infusate at room
temperature through a guide catheter. Average intracoronary temperatures were reduced
to 3.4℃ below body temperature and infusate flowrates were delivered between 60
ml/min and 100 ml/min proximal to the occlusion. A predetermined temperature of 30℃
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was set as a threshold to avoid the risk of hypothermia complications during infusate
perfusions. Out of the ten patients included in the study, three occlusions were evident in
the proximal LAD, two in the Mid-LAD, one in the LCX, and four in the RCA [96].
Advantages of localized cooling. In vivo trials reduced areas of heart tissue by 3℃
in 5 mins using 30 W of cooling [92]. Rapid, localized cooling of heart tissue generally
does not impact core body temperatures [94], and provides approximately ten times the
cooling rate to that of external cooling devices, offering ~1℃ per minute compared to
0.1℃ per minute [97].
A significant advantage to organ specific cooling is its ability to leverage the
reduced thermal inertia, which results in rapid cooling of the myocardium. Since the
product of mass and specific heat yield cooling capacity, it will be much quicker to cool a
portion of a 310 gram heart than an entire 62 kilogram patient. Thus, cooling rates are
significantly greater using localized cooling methods, which is a preferred method to use
following an ischemia event [13][98][96]. Additionally, localized TH may serve as an
effective co-therapy for angioplasty procedures.
Disadvantages of localized cooling. Localized organ cooling is a relatively new
therapy and requires a substantial amount of research to assess its impact on damage
caused to heart muscles across a broad spectrum of patient-specific vascular structures.
Large clinical trials are needed to replicate localized cooling results from isolated pig
heart studies [13] and small trials treating patients with STEMI [96]. There are major
differences between localized cooling results from artificial occlusions in pig hearts and
AMI in humans [99]. Lastly, optimal TH intracoronary temperatures have not been
established for effectively reducing ischemia reperfusion injury [74][100]. Table 1.1
provides a comparison between current TH methods.
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Table 1.1
Comparison between current TH treatment methods.
TH
Hypothermia
Cooling
Method
Location
Rate
External
External
3°C/hr
Cooling
Whole-body
Cooling
Pads
Blankets

ASTT*

Effective

Endovascular
Whole-Body
Devices

3°C/hr

IVC*
Cooling

Whole-body

More
Effective

Localized
Cooling

3°C/5 min

LMCA*
Cooling

Heart specific

Most
Effective

AdverseEffects
Frequent wound
infections &
disturbed
shivering
Substantial
research needed

Note. *IVC = Inferior Vena Cava, *LMCA = Left Main Coronary Artery, *ASTT =
Accuracy at Sustaining Target Temperatures.

What others have done to examine the biophysics of heart cooling. Studies
involving the biophysics of heart cooling remain elusive, specifically, the biophysics of
coronary artery cooling following MI. Experimental studies have explored myocardial
protection techniques using computer simulations to examine topical cardiac cooling
[101], as well as conjugate heat transfer by computationally pumping cold liquid through
the major cardiac chambers [102].
The majority of computational cardiac biophysics research targeted towards the
coronary arteries have focused primarily on computing and visualizing hemodynamics
(i.e. coronary blood shear, pressure, and velocity) [4][103][104][105], coronary artery
fractional flow reserve (FFR) [106], and lumped parameter modeling [75][107]. A
lumped parameter model is a mathematical model that describes the physiological
constraints of a system using systematic mathematical calculations [108]. To our
understanding, there is no explicit literature analyzing the biophysics of localized cooling
in patient-specific coronary arteries.
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What is not well understood? The structural properties of the heart and its impact
on thermal fluid behavior are poorly understood [92], [94], [109], [110]. A study
performed by Otterspoor, 2018 involved the use of lumped parameter modelling to
mathematically predict myocardial temperatures from intracoronary arterial temperature.
However, higher fidelity and more complex calculations using computational fluid
dynamics (CFD) modelling were not used, which could provide clinically significant
physics-based models representing patient-specific vascular structures. CFD modelling
methods are ideal tools to help determine the preferred flows and temperatures of
intravascular GuideLiner® infusions for patient-specific procedures [13].
Problem Statement
Significance of work. The link between thermal fluid behavior and the structural
geometry of the coronary arteries has not been sufficiently studied [95], [111]–[113].
Thermal fluid models of heart cooling, as well as models that predict arterial blood and
myocardial tissue temperatures in patient-specific hearts do not currently exist [13].
Objectives of study. In this study, patient specific LAD and LCX artery models
are used to help determine the impact of thermal fluid behavior from TH treatment
methods [13]. A new thermal modeling approach is introduced that could provide a better
understanding of the biophysics of AMI during TH, as well as provide insight to guide
more efficient TH device designs and operation parameters [92].
We aim to gain insight in determining distinguishable temperature behavior
between six patient-specific LAD and LCX arteries by comparing temperature
distributions of different coronary artery geometries and surface area variations. We also
seek to reveal the effect of catheter flow rate on patient-specific temperature distributions
in each LAD and LCX artery vasculature. The evaluation metric for comparison between
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models will be the measured distance of TH fluid temperatures along the fluid pathway.
Success will be the result of TH fluid temperatures exiting the artery outlets.
The objective of this study is to create thermal fluid models of TH in six patientspecific human LMCA’s predicting arterial blood temperatures for a variety of hearts and
catheter infusion flow rates in the proximal LAD and LCX vasculature. CFD models can
help determine and qualitatively analyze temperature distributions in the LMCA’s. They
can shed light on TH device design and operation to optimize patient outcomes following
AMI.
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Chapter 2
Biophysics Background
The following chapter provides the biophysics background and describes the
fundamental governing equations required to solve fluid mechanics and heat transfer
problems in a human heart vascular network. This chapter will discuss the governing
equations used in our computational models including conservation of linear momentum and
conservation of thermal energy. The end of the chapter will describe an equation for solving
dynamic viscosity as a function of shear rate, hematocrit, and temperature.

Laminar Flow: Conservation of Linear Momentum
Governing equations. The Navier-Stokes equations describe the conservation of
linear momentum for fluid flow in three-dimensional space, and are represented in
Cartesian coordinates as the following [114]:
𝜕𝑢

𝜕𝑢

𝜕𝑢

1 𝜕𝑝

𝜕2 𝑢

𝜕2 𝑢
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𝑢 𝜕𝑥 + 𝑣 𝜕𝑦 + 𝑤 𝜕𝑧 = − 𝜌 𝜕𝑥 + 𝜈 𝜕𝑥 2 + 𝜈 𝜕𝑦 2 + 𝜈 𝜕𝑧 2
𝑢 𝜕𝑥 + 𝑣 𝜕𝑦 + 𝑤 𝜕𝑧 = − 𝜌 𝜕𝑦 + 𝜈 𝜕𝑥 2 + 𝜈 𝜕𝑦 2 + 𝜈 𝜕𝑧 2
𝜕𝑤

𝜕𝑤

𝑢 𝜕𝑥 + 𝑣 𝜕𝑦 + 𝑤 𝜕𝑧 = − 𝜌 𝜕𝑧 + 𝜈 𝜕𝑥 2 + 𝜈 𝜕𝑦 2 + 𝜈 𝜕𝑧 2

(2.1)
(2.2)
(2.3)

𝜇

where 𝜈 represents the kinematic viscosity having the form 𝜌, where 𝜇 is the dynamic
viscosity as a function of temperature and shear rate.
Blood will be considered as an incompressible, Newtonian fluid, since the viscosity
is dependent on shear rate [139][140], with a constant (or average) shear rate assumption.
As a result, viscosity will only vary with temperature, providing there is coupling between
the energy and Navier-Stokes equations. This concept will be described in further detail
later in this chapter.
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Pulsatile flow is a natural phenomenon that occurs in physiological systems, such
as the human respiratory and circulatory system [17]. However, the heat transfer coefficient
for steady and pulsatile flow are equivalent [115][116], and studies have shown that
pulsating effects have no impact on heat transfer in blood flow [117][118]. Therefore,
pulsating flow effects were disregarded and steady state simulations were used to solve for
ABT distributions that would typically reflect pulsatile flow conditions.
Steady state flow occurs when the fluid properties, such as temperature and mass
flow rate, are unchanging over time for any single point in the system. Steady state
simulations are also computationally cost efficient since they typically complete using
significantly less CPU time than unsteady state simulations. For this reason, steady state
CFD simulations are typically used as a starting point to verify that physics conditions and
fluid properties are accurately solved [119]. Therefore, for this research, steady state, 3dimensional laminar flow will be assumed.
Governed by the laminar Navier-Stokes equations of conservation of linear
momentum (2.4a), and the continuity equation of conservation of mass (2.5), the equations
employed in this study can be written in the following form [120]:
𝑑𝑉

𝜌 𝑑𝑡 = 𝜌𝑔 − 𝛻𝑝 + 𝜇 · 𝛻 2 𝑉

(2.4a)

𝛻 · 𝑉=0

(2.5)

where 𝑉 is the fluid velocity, 𝛻 denotes the operator, ρ is the density of the fluid, 𝑔 is
gravity, p is the pressure of the fluid, and μ is the dynamic viscosity of the fluid. Equation
2.4a is the more frequently seen version of the Navier-Stokes equations. However, for
this work, we will use a non-constant viscosity encapsulated by the more general form of
Navier-Stokes:
𝑑𝑉

𝜌 𝑑𝑡 = 𝜌𝑔 − 𝛻𝑝 + 𝛻 ⋅ 𝜇(𝛻𝑉)
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(2.4b)

where the viscous stresses inside of the divergence operator come from 𝜇 times the
velocity gradient. Since the Navier-Stokes equations indicate a force per unit volume, the
viscous force (per unit volume) is resultant of viscous stress (per unit area), where area
forces are integrated to volume forces which are reconciled through the divergence
theorem [121]. The viscous terms are then split between equations 2.4a and 2.4b,
resulting in the external divergence operator as seen in Eq. 2.4b [115].
In cylindrical coordinates, the gradient operator 𝛻 represents the following in
three dimensions:
𝜕
1 𝜕
𝜕
𝛻 = 𝜕𝑟 𝑟̂ + 𝑟 𝜕𝜃 𝜃̂ + 𝜕𝑧 𝑧̂

(2.6)

where 𝑟̂ , 𝜃̂, and 𝑧̂ are unit vectors associated with their corresponding r, 𝜃, and z
directions in cylindrical coordinates. Equations 2.1 to 2.5 represent the foundation of all
computational fluid dynamics (CFD) modeling. Chapter 8 describes the innovative
approach of this work and limitations of the before mentioned assumptions.
Laminar Flow: Conservation of Thermal Energy with constant wall temperatures
Governing equations. The thermal energy equation for an incompressible fluid
that satisfies the continuity equation (Eq. 2.5) can be described as a 3-dimensional problem
with no kinetic energy or time derivative of pressure
𝜕𝑇

𝜕𝑇

𝜕𝑇

𝜕2 𝑇

𝜕𝑝
𝜕𝑡

, having the form [114]:
𝜕2 𝑇

𝜕2 𝑇

𝜌𝐶𝑝 [𝑢 𝜕𝑥 + 𝑣 𝜕𝑦 + 𝑤 𝜕𝑧 ] = 𝑘 [𝜕𝑥 2 ] + 𝑘 [𝜕𝑦 2 ] + 𝑘 [𝜕𝑧 2 ]

(2.7)

where the specific heat, 𝐶𝑝 , and thermal conductivity, k, are assumed constant, T is the
absolute temperature, and the terms on the right side of the equation represent the rate of
thermal diffusion.
Eq. 2.7 is coupled with Eq. 2.4 because the viscosity, 𝜇(𝑇) is a function of
temperature, where T is determined from Eq. 2.7. Therefore, Eq. 2.4 and Eq. 2.7 are
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coupled to solve for each iterative temperature and viscosity along the fluid flow path,
respectively. These values are then used as inputs to solve for fluid flow in the NavierStokes equations (Eq. 2.1 - 2.3). Appendix A contains detailed derivations of the fully
developed velocity profile, energy balance, and the temperature dependent heat source
equation in cylindrical coordinates. Additional information regarding CFD modeling
methods will be discussed in greater detail in Chapter 3.
Post-Processing
The average bulk temperature (ABT) in fluid flow is the mean temperature of the
fluid’s cross section [115]. For complicated LMCA networks, the ABT changes in the
direction of flow and is a critical post-processing component for determining LMCA
outlet temperatures. The rate of energy flowing through a cross section is considered
equivalent to the energy rate travelling through said cross section with a constant fluid
temperature [115]. Therefore, the flow rate of thermal energy of the fluid can be
expressed as the following:
̇
𝐸𝑓𝑙𝑢𝑖𝑑
= 𝑚̇𝑐𝑝 𝑇𝑚 = ∫𝐴 𝜌𝑢𝑐𝑝 𝑇(𝑟, 𝑥)𝑑𝐴𝑐
𝑐

(2.8)

where 𝐴𝑐 is the cross-sectional area, 𝑇𝑚 is the mean temperature, 𝜌𝑢 is the mass flux,
where 𝑢 has (𝑟, 𝑥) dependence, and 𝑐𝑝 𝑇(𝑟, 𝑥) is the internal energy per unit mass. Thus,
assuming a circular boundary, solving for mean temperature yields:
𝑇𝑚 =

∫ 𝜌𝑢𝑐𝑝 𝑇(𝑟,𝑥)𝑑𝐴𝑐
𝑚̇𝑐𝑝

𝑟𝑜
2 ∫0 𝑢𝑇(𝑟, 𝑥)𝑟𝑑𝑟
𝑟
𝑚 𝑜

=𝑢

2

(2.9)

where 𝑢𝑚 is the mean velocity, and 𝑟𝑜 is the radius of the cross section of interest.
Properties
When non-isothermal fluids experience a temperature change, the material
properties, such as density and viscosity, are also subject to change [122]. Determining
the material properties of a fluid is a critical step in solving fluid dynamics problems. The
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physics of fluid dynamics simulations hinge upon material properties that accurately
reflect the properties of the problem being solved.
Dynamic viscosity. Dynamic viscosity (µ) for the mixed blood and distilled
water in the LAD and LCX arteries was modelled using an equation derived by Cheung
et al. 2000 [123]. The model was used in our study to calculate the viscosity of the mixed
fluid between 0 and 40 °C. The Dynamic viscosity is a function of shear rate, hematocrit,
and temperature, and can be expressed as:
𝜆

ϕ
µ(Υ̇, Hct, 𝑇𝑚 ) = (𝑒 Υ̇+ƞ⋅𝐻𝑐𝑡 )[𝛼 + (1+𝑒 𝛽(𝑇𝑚−Є))]

(2.11)

where the shear rate (Υ̇), hematocrit value (Hct), and mean temperature (𝑇𝑚 ) are
independent variables and the dynamic viscosity is the dependent variable for this
solution. The remaining coefficients, λ, ƞ, α, ϕ, β, and Є, represent predetermined values
derived by Cheung et al. 2000 [123]. A total mixed Hematocrit value was determined for
each of the catheter flow rates, and an average shear rate was calculated for each of the
six LMCA models. Therefore, equation 2.11 is simplified to become:
ϕ

µ(𝑇𝑚 ) = 𝐶 ⋅ [𝛼 + 1+𝑓(𝑇 )]
𝑚

(2.12)

where 𝐶 is a constant, and 𝑓(𝑇) is how equation 2.7 is coupled to the Navier-Stokes
equations (2.1 to 2.3). The common Newtonian form of the Navier-Stokes equations (Eq.
2.4) is now extended to non-Newtonian fluids, which now requires the energy balance
equation to solve for temperature.
The treatment of hematocrit and shear rate effectively prescribes a vasculaturespecific Newtonian flow for each LMCA simulation. Additionally, full non-Newtonian
treatment would require significantly more complex analysis [124][125].
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Chapter 3
Computational Methods
A number of computational methods were required to solve the thermal fluid
modeling work described this thesis. The modeling workflow and CFD simulation
process is described in detail.
Materialise Mimics® Workflow
Mimics (Materialise’s Interactive Medical Image Control System) Innovation
Suite 20 is one of Materialise’s high-end processing tools used to create 3D models from
2D cross-sectional computed tomography (CT) or magnetic resonance imaging (MRI)
medical image stacks [126].
DICOM Image Sets to 3D Vasculature Creation
The images employed in this study consist of image stacks known as DICOM
(Digital Imaging and Communications in Medicine) image files [127]. DICOM images
are typically attained from hospitals and/or doctors and are used to analyze specific
organs of the body. DICOM defines the international standard for format use of medical
images that satisfy the quality and requirements to transmit, store, and process clinical
use imaging information [127]. For this study, the DICOM image sets consisted of CT
angiography axial image stacks with an average slice thickness of 0.942 mm ± 0.3, a
plane resolution of 512 x 512 pixels, and an average pixel resolution of 0.377 mm ±
0.085. The source of where the DICOM images came from and rationale for selecting
specific human heart models is discussed in Chapter 5.
DICOM files were imported into Mimics Innovation Suite 20 (Mimics®) as
stacks of axial images in the XY plane (axial plane). Mimics® interpolates the image
stacks to produce a 3D impression of the model (Fig. 3.1) by creating images in the XZ
and YZ planes for the coronal and sagittal views, respectively.
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b.
a.
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Figure 3.1. 3D volume rendering window in Mimics® of the LMCA segmented from 2D
CT angiography image scans of HH55. The views in the window pane consists of the
coronal (a), axial (b), sagittal (c), and the 3D rendering window (d). Green highlighted
pixels (c) represent the segmented blood flow path of the artery network. The fully
segmented 3D model (d) represents a patient-specific structure that can be exported in
STL format and used in CFD simulations for thermal-fluid flow analysis.

Segmentation approach. CT scanners produce medical images that exhibit
grayscale information. Mimics utilizes the grayscale information by enabling the user to
highlight individual grayvalues, known as Hounsfield units, within each image [126].
Grayvalues are numbers that represent each pixel on an image that correlate to both the
density and shade (black, white, or gray) of the pixel. Mimics groups together similar
grayvalues so that an image can be segmented; a process used to convert anatomical
image data sets to 3D models. During segmentation, the vasculature of interest for each
pixel of the data set images was highlighted. This data was then translated from the
segmented images to create a 3D model of the accentuated vasculature [126]. This
method is known as thresholding and was used to create accurate 3D representations of
the accentuated physiological LMCA models [126].
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STL format. Mimics® models were exported in stereolithography (STL) format
(Fig. 3.2, Step 3).

1.

DICOM

2.

Mimics & 3-matic

4.

3.

STL

SolidWorks
HH55 LCX

Vascular Solutions GuideLiner®

5.0mm
1.57mm

Figure 3.2. DICOM to SolidWorks editing workflow. DICOM images were attained from
the Visible Heart Lab, University of Minnesota (Step 1) and imported into Mimics for 3D
model segmentation and 3-matic smoothing (Step 2). The Mimics/3-matic models were
exported in binary STL format (Step 3) and imported into SolidWorks for inlet/outlet
trimming and creation of the proximal GuideLiner® insertion (Step 4).

STL files represent the surface geometry of 3D objects using a triangulated
surface mesh without representing the color or texture of the object of interest. The
surface geometry of STL files are encoded with triangular configurations such that there
are no gaps or overlaps in the outer-surface portrayal, or shell, of the model’s vasculature.
This meshing structure allows for a simple, yet accurate representation to match most
complex geometry structures. STL files are generated as compact binary versions of a
model, which can be imported into 3D engineering programs for post processing [128]
and computer aided design (CAD) manipulation [126].
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Materialise 3-Matic Model Smoothing
The Mimics® STL files were exported into Materialise 3-matic, an extension of
Materialise’s engineering software tools that enable detailed design manipulation of STL
files. This software was used to perform advanced editing and remeshing of the STL
LMCA models, such as trimming sharp edges and filling holes in the mesh that were
created during the segmentation process.
SolidWorks Editing
With an STL file formed by Mimics and the original DICOM data set, the binary
STL files from the LAD and LCX heart models were imported into a 3D computer-aided
design (CAD) modeling and editing tool, SolidWorks®, where the inlet and outlets were
orthogonally trimmed (Fig. 3.3).
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Outlets

Outlets

Inlet

Figure 3.3. With an STL file formed by Mimics and the original DICOM data set, a 3D
modeling and editing tool, SolidWorks® was used to orthogonally trim the inlet and
outlets of each LAD and LCX artery model. The following HH55 LCX model contains a
single inlet and 33 outlets, however, the number of outlets varied with each LAD and
LCX model employed in this work.

When Mimics® STL files are exported into SolidWorks®, the geometry of the
model slightly changes, which leads to an increased risk of surface repair and meshing
issues. Each software tool that is used to refine and edit the model contributes to a
possible surface meshing issue, which could cause simulation errors in computational
modeling work. Therefore, these errors should be identified and remedied in each
software tool. For example, holes in the surface mesh were identified in 3-Matic and
filled to ensure no surface meshing errors carried over into STAR-CCM+.
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Brief Description of Siemens STAR-CCM+ Workflow
Finite volume method. The Finite Volume Method (FVM) is a computational
method used to solve complex problems involving partial differential equations (PDE’s).
The FVM uses a discretization process that interprets a set of governing equations
defined on a computational domain. The domain is discretized into a system of structured
control volumes, or cells (Fig. 3.4) [114].

Node

Physics Space

Control Volume

Figure 3.4 The physics space (1) in a simple bent tube is comprised of a grid that
encompasses the computational domain. At each node (2), the governing equations in
algebraic form are created. If we combine 1 and 2, a system of equations can be used in
STAR-CCM+ to solve the flow field [129].

The FVM approximates a formation of ordinary differential equations (ODE’s)
that describe the computational mesh comprising of the minute control volumes (i.e.
cells, elements) [114][130]. These equations employ iterative solvers that are able to
compute numerical solutions in the computational domain space per unit time. A more
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accurate solution can be obtained by refining the mesh within the boundary conditions,
which provides a more precise assessment of the ODE solvers in the physics domain.
FVM mathematics. Conservation laws from the Navier-Stokes equations are
applied in integral form when solving FVM [131]. A succession of finite control volumes
permeates the computational domain and are executed in the physical space using
identical coordinate systems. To describe how FVM works mathematically, consider the
incompressible continuity equation (Eq. 2.2) from Chapter 2, where 𝛻 · 𝜈 = 0.
Integrating Eq. 2.2 over a control volume for an incompressible fluid where ρ is constant,
yields:
∫𝑣 𝛻 · 𝑣 𝑑𝑉 = 0
𝑖

(3.1)

where 𝑣 is the fluid velocity, dV is the volume element, and 𝑣𝑖 is the control volume
integrated over the surface. Applying the divergence theorem, we obtain:
∮𝑆 𝑣 · 𝒏𝑑𝑆 = 0
𝑖

(3.2)

where 𝒏 is the unit normal to the volume element and dS is the surface area of the
volume element. Thus, Eq. 3.2 represents a boundary integral typically used in FVM
analysis describing the continuity for a control volume [132].
The governing equations described in Chapter 2 are discretized into algebraic
equations that are solved across the computational domain at discrete locations to
numerically represent fluid flow and heat transfer values. The mesh representing the
computational domain is a three-dimensional discretization that should represent
independence of the governing equations from additional mesh refinements.
Boundary conditions applied to FVM. To get a better understanding for how
the Navier-Stokes (NS) and Thermal Energy equations work together to solve CFD
problems, a general correlation to boundary conditions can be expected (Table 3.1).
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Table 3.1
Characteristic CFD Boundary Conditions and Relationship to Navier-Stokes and
Thermal Energy.
Boundary Condition
Navier-Stokes
Thermal Energy
In

𝑚̇

𝑇𝑖𝑛

Out

P=0

𝛿𝑇
=0
𝛿𝑠

Wall

Velocity = 0

𝑇𝑤𝑎𝑙𝑙 = 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡

The NS boundary condition entering our inlet region represents flow that is fixed
to typical mean flows, while NS at each of our outlet regions represents P = 0, meaning
there is no backpressure acting on our system at the outlets. NS for the walls signify a
zero velocity no slip boundary condition represented by a fixed (stationary) wall. The
Thermal Energy entering our inlet region represents physiological blood temperature at
the artery inlet and chilled saline temperatures at the GuideLiner® inlet. Exact
temperatures are listed in Chapter 4. Thermal Energy exiting our domain is built on our
assumption of having sufficient vascular lengths such that the gradient along the vessels
are negligible. Lastly, our Thermal Energy boundary condition acting at the walls
represents a constant, isothermal physiological body temperature.
Since NS is especially useful in solving fluid dynamic simulations, while thermal
energy is utilized to solve heat transfer phenomena, the two can be coupled together to
denote distinct boundary conditions used in solving our CFD models. Although NS and
Thermal Energy equations work together in CFD heat transfer simulations, they are
contingent upon dynamic viscosity, 𝜇, and its associated temperature.
More complicated thermal boundaries could be envisioned in lieu of 𝑇𝑤𝑎𝑙𝑙 =
𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡, however, at present, no work yet exists even for isothermal walls. Therefore,
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the effect of vascular branching and concentrated heat sources from close branches can
be ignored.
Mesh convergence. A mesh convergence analysis is required to attain an
optimum mesh. If the mesh contains large cells, the number of cells in the mesh would be
minimal (Fig. 3.5) and the temperature would vary dramatically below the optimum

Average Bulk Temperature (°C)

number of cells.

Optimum Number of Cells

Number of Cells in Mesh
Figure 3.5. Mesh convergence analysis comparing the number of cells in a mesh and a
corresponding ABT on a cross sectional plane.

On the other hand, if the mesh contained very small cells so that the number of
cells in the mesh approached infinity, the mesh would require extensive computational
times and would only vary the resultant temperature slightly. Therefore, a mesh
convergence analysis is required to obtain an optimum number of cells so that resulting
temperatures are most accurate and computational times are at a minimum.
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Siemens STAR-CCM+. Siemens STAR-CCM+® is a commercially available
finite element analysis software platform used to solve complex and accurate physics
simulations including fluid dynamics, heat and mass transfer, solid mechanics, and
related phenomena [133]. All of the models in this study were executed using STARCCM+ (version 13.04.010), where FVM was employed as a discretization process that
transformed PDE’s into explicit algebraic equations so that numerical solutions could be
determined. In Chapter 6, the computational domains will be described as a mesh with
appropriate discretization for solving fluid flow and temperature distributions in patientspecific coronary arteries.
A synonymous description for STAR-CCM+ modeling is the term computational
fluid dynamics (CFD), which refers to the use of high-speed computers for computing
mathematical simulations of real-life physical events or processes [114]. The goal of
CFD software packages is to analyze and predict fluid flow, heat and mass transfer, and
chemical reactions using numerical simulations to solve for conservation of mass,
momentum, and energy [114]. CFD analysis offers a comparable alternative to traditional
experimentation and testing by providing a low cost, finite element model substitution.
Regardless of which software package is used for CFD simulations, the same approach is
required to simplify and solve for the solution. The typical CFD workflow is best
described by the following flowchart (Fig. 3.6):
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IDENTIFY MODELING GOALS

PRE-PROCESSING


Define model geometry/domain



Create mesh



Set material properties



Set boundary & initial conditions



Select modeling physics

CFD SOLVERS


Define Governing Equations



Identify convergence criteria



Employ monitor plots



Initialize solution

REVISE MODEL

POST-PROCESSING


Residuals plot



Velocity profile



X-Y graphs

Figure 3.6. The general CFD modeling approach that describes the necessary steps for
preparing and appropriately executing a CFD simulation [114].

All CFD simulations use a similar approach to Fig. 3.6. The first step is to clearly
define the aims of the simulation prior to defining the geometry and creating the mesh.
Additionally, one must ensure that the correct physics models are employed in the solver,
and that the solution fully converges. Since CFD modeling provides an alternative to
experimental development, CFD studies must always be scrutinized and compared with
experimental results and published data to validate each model’s credibility [134].
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Computer hardware. All Mimics® modeling, SolidWorks® editing, and STARCCM+® simulations were executed using an XI M Tower 2P64X Workstation with a
3.70 GHz Intel Xeon Quad-Core processor and 32.0 GB of RAM running Windows 10
Pro 64-bit Operating System. This workstation will be referred to in Chapter 6 as
workstation 1 (WS1). Minor post-processing manipulations including custom plane
creation along the artery pathway, cross-sectional ABT reports, and scalar temperature
and streamline images of the LMCA were executed using a Dell Inspiron 15 7000 Series
with a 1.60 GHz Intel Core i5 processor and 8.0 GB of RAM running Windows 10
Education 64-bit Operating System. This workstation will be referred to in Chapter 6 as
workstation 2 (WS2).
Modeling objective. In summary, this chapter describes the workflow from
obtaining DICOM image files to creating patient-specific 3D LMCA models for CFD
simulations. Since the goal is to create thermal fluid models of TH in six patient-specific
human LMCAs, this chapter serves as a foundation to solving the thesis objectives.

35

Chapter 4
In Vitro Methods
In Vitro Setup
This chapter presents the in vitro mock loop, including the equipment and
calibration methods used to measure temperate and flows in a cardiovascular system. The
objective of the in vitro mock loop testing was to use the GuideLiner® outlet temperature
and flowrate data as inlet conditions in our computational fluid dynamics (CFD) models.
This in vitro study replicated physiological blood flow and temperature conditions
and provided realistic data to use in our CFD simulations. The mock loop system
provided a rapid and accesible phyioslogical enviroment to accurately test and record the
outlet temperatures and flow rates for the 7F Cordis Vista Brite® guide and guide
extension in conditions similar to in vivo.
The following bullets are steps needed to obtain this objective:


Calibrate thermocouples, pressure sensors, and flow meters.



Update and execute mock loop protocol.



Place the Cordis Vista Brite® 7F guide catheter in the mock loop and measure
Vascular Solutions GuideLiner® outlet temperatures for a variety of flowrates
using distilled water. In this chapter, the guide catheter will be called the
“guide” and the GuideLiner® will be called the “guide extension”.

Mock loop geometry. An in vitro mock loop from Merrill et al. [93][94] was
rebuilt and modified to simulate the cooling performance of a standard catheter in the left
main coronary artery (LMCA) vasculature (Fig. 4.1). The in vitro loop comprises of
Tygon tubing networks, valves, and fittings that represent a controlled mock loop of the
femoral, aortic, and coronary vascular systems.
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Figure 4.1. Schematic of modified coronary mock loop showing catheter path and mock
vessels [93]. The guide (represented by solid blue line) is inserted into the femoral
insertion sheath and advanced through the glass aorta into the LMCA ostium. The table at
the bottom of the schematic describes the sizes and proper flow rates for vessels of
interest.

The cardiovascular mock loop system circulates distilled water at physiological
flows, pressures, and temperatures through a glass aorta. A second portable loop system
pumps distilled water through an external heat exchanger and into the proximal hub of
the guide. The guide was inserted into an insertion sheath through the femoral artery
access point of the glass aortic arch and advanced and fixed at the ostium of the LMCA.
A full-size glass replica model of the aortic arch (Vasodyn, Freeville, NY) was
positioned at the center of the test loop (Fig 4.2), and from it stems left and right coronary
artery access points, as well as a femoral artery access point for blood (distilled water)
removal and catheter insertion.
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LMCA Flow

CCA Flow

Guide Extension Outlet
Catheter Outlet

TC LMCA
TC Aorta/Core

Pressure Sensor
Aorta Flow

Catheter Shaft
with GuideLiner ®
From Flow Meter
and Pump
Figure 4.2. Image of coronary mock loop showing catheter path and mock vessels. Note:
Thermocouple (TC), common carotid artery (CCA), and left main coronary artery
(LMCA). Flow from the large reservoir is pumped through a flow meter before entering
the Tygon tubing as proximal Aorta flow. Flow enters the Aortic arch and disperses into
the coronary artery ostia where it continues to the left main coronary artery (LMCA) and
the guide extension outlet. Aortic flow exits through the common carotid artery (CCA)
and femoral arteries downstream.

Rather than a glycerol water mixture, which more closely resembles blood
properties, we chose to use distilled water. The justification for using distilled water as a
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fluid in the in vitro mock circulatory loop was due to the forced convection parameters
from the non-dimensional Reynolds (Eq. 4.1) and Prandtl numbers (Eq. 4.2) [115][116]:
𝜌𝑉𝐷

𝑅𝑒 =

(4.1)

𝜇
𝐶𝑝 𝜇

𝑃𝑟 =
𝑘𝑔

(4.2)

𝜅
𝑚

Where 𝜌 is density (𝑚3 ), 𝑉 is velocity ( 𝑠 ), 𝐷 is diameter (𝑚), 𝜇 is dynamic
𝐽

𝑊

viscosity (𝑃𝑎 ⋅ 𝑠), 𝐶𝑝 is specific heat (𝑘𝑔⋅𝐾), and 𝜅 is thermal conductivity (𝑚⋅𝐾).
The Reynolds number is a dimensionless value that describes the ratio of inertial
to viscous forces and characterizes laminar (Re < 2300), transient (2300 < Re < 4000) or
turbulent flow (Re > 4000) acting in a fluid [115]. The Prandtl number is a dimensionless
parameter that characterizes the ratio of diffusion for momentum with respect to heat
within a fluid [116]. The dimensionless values for Equation 4.1 and 4.2 are compared to
each other and presented in Table 4.1.

Table 4.1. Dimensionless values for Reynolds and Prandtl numbers assuming 68.85
mL/min inlet flow rate and 0.003m inlet artery diameter.
Re x Pr
Fluid
Re
Pr
Re x Pr
Difference (%)
Distilled
487
7.0
3404.2
Water
2.05
Blood
162
20.5
3334.2

The difference in dynamic viscosity between the blood (0.003 Pa⋅s) and distilled
water (0.001 Pa⋅s) resulted in a 100.15% overall difference in Re. However, a small
difference of 2.05% resulted between comparing (Re) x (Pr) of the blood and distilled
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water. Since these latter differences are small, the distilled water should closely predict
warming. Therefore, the distilled water was chosen for ease of use in this pilot work.
A large reservoir containing distilled water (Fig. 4.3) is circulated and maintained
at physiological temperatures (37⁰ C ±5) using an immersion heater (George Ulanet Co.
Newark, NJ) controlled by a temperature feedback controller (Cole-Parmer, Vernon
Hills, IL) and peristaltic circulation pump (Ismatec SA, Glattbrugg, Switzerland). A
custom dampening cylinder is secured downstream to the peristaltic pump to reduce
vibration at high flow rates.

From Pump
LMCA Flow

To Reservoir
with Heater
LCA Flow Meter

CCA Flow

Flow Control Valves
Drain Valve

Figure 4.3. Continuation of Fig. 4.2 showing catheter path and mock vessels. Distilled
water is heated in the reservoir and pumped into circulation via the peristaltic pump.
Flow to the common carotid artery (CCA) and left main coronary artery (LMCA) can be
adjusted using flow control valves downstream.

Flow rates. Distilled water was used as the chilled infusate flow through the
catheter at 10 mL/min to 90 mL/min flowrates, as well as the blood throughout the
system. Flow was varied using control valves to alter flow dispersions throughout the
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mock circulatory loop. Flow was measured at various locations throughout the loop using
two turbine flow meters (McMillan, Georgetown, TX), and a transonic flow meter
(Transonic Systems Inc., Ithaca, NY). Equipment specifications and employed use for
each flow meter are listed later in this chapter.
To circulate and measure blood flow about the catheter in the coronary lumen, a
Tuohy Borst Adapter (Fig. 4.4) with side port (Qosina, Ronkonkoma, NY) was connected
to the LMCA ostium.

TB Adapter w/Side Port

Figure 4.4. The Cordis® catheter enters the ostium of the LMCA and the guide extension
is advanced 8.5cm through the Tuohy borst adapter (TB Adapter), out of the catheter, and
positioned in tight fit tubing. The fittings and catheter are insulated (not shown) after
assembly. The “To Reservoir” label represents flow advancing towards the LMCA flow
meter and into the mock loop reservoir. The “To Graduated Cylinder” label refers to
infusate flowing towards the reservoir (or graduated cylinder), which is used to measure
guide extension flowrate.

The sideport redirected coronary flow to a turbine flow meter (McMillan,
Georgetown, TX) and into the large reservoir. The guide extension was advanced 8.5 cm
out of the catheter and through the Tuohy Borst outlet. Tight fit tubing extended the guide
extension and a type-T thermocouple was positioned 3 cm distal to the Touhy Borst
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outlet and used to measure the temperature of the chilled infusate leaving the catheter. To
ensure that average bulk temperatures were being measured, the entire flow path would
be insulated from the exit of the GuideLiner® to the thermocouple, and would
incorporate an in-line static mixer directly upstream of the thermocouple. For this work,
the distance between the distal tip of the GuideLiner® and the temperature measurement
point was minimized, which reduced heat loss and the need for insulation, and the fittings
between the distal tip and temperature sensing location mixed the fluid at the point of the
thermocouple.
Flow rates at critical locations in the in vitro mock loop are described in Table
4.2.

Table 4.2
Critical flowrates and locations in mock circulatory loop.
Location in Mock Loop
Flow rate (ml/min)
3500 ±150
Aorta
145 ± 15
LMCA
10 – 90 ml/min
Guide Extension Outlet

Reference
[93]
[10][11][12]
[13][96]

Temperatures. Type-T thermocouples (Physitemp, Clifton, NJ and Blaze
Technical Services, Stow, OH) were used to measure the catheter inlet and outlet, aorta,
and heat exchanger outlet temperatures Table 4.3.

42

Table 4.3
Make and sizes of thermocouples used to measure guide inlet, guide extension outlet,
heat exchanger, and aorta temperatures.
Needle
Sheath
TC Location
Make
Model Number
(Tip)
TC Length
Diameter
Length
Physitemp
MT26-2 HT
0.018”
2 cm
5 ft
Guide Inlet
Guide
Physitemp
MT26-2 HT
0.018”
2 cm
5 ft
Extension
Outlet
Heat
Physitemp
MT26-2 HT
0.018”
2 cm
5 ft
Exchanger
Omega
TMQSS 040G
0.040”
6 in
N/A
Aorta (Core)
Note. Thermocouple = TC.

Type-T Thermocouple accuracy as rated by the manufacturer is ±0.1°C. If noise
or differences in simulation results for ABT are without the range of ±0.1°C then the
results will not be accurately measured and values within this range will be disregarded.
A high-accuracy pressure transducer (Cole-Parmer, Vernon Hills, IL) measured
the pressure entering the aorta, and all instrumented measurement data was recorded
using LABVIEW (National Instruments, Austin, TX) DAQ software.
A total of 5 thermocouples were used in the mock loop system to measure the
temperature at the catheter inlet and outlet, Aorta (core body temperature), chilled
distilled water leaving the heat exchanger, and the Ambient (room) temperature. The
mock loop core temperature, 37℃, was regulated by the reservoir heater and LabView
control algorithm and was measured using a type-T thermocouple positioned upstream to
the LMCA ostium in the glass aorta. The external cooling console (Fig. 4.5) was set to
0℃ and pumped the chilled distilled water through a heat exchanger and into the proximal
end of the guide.
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a. Peristaltic
Pump
4. Chilled Flow
to Mock Loop
1a. Flow from
Reservoir

3. Cold in to HX

b. Heat Exchanger
(HX)

1b. Flow from
2. Cold out to Chiller
Peristaltic Pump
HX
Figure 4.5. Internal view of custom built portable cooling console. The peristaltic pump
(a) circulates flow from a small reservoir to the heat exchanger (b). Distilled water is
chilled through the heat exchanger and advanced into the mock circulatory loop (4) by
way of the Guide Catheter.

Chilled flow entering the proximal hub of the Cordis catheter was pumped using a
custom built portable cooling console. The portable cooling console was mounted on a
cart for easy maneuverability and Tygon tubing was used to join the cooling console to
the catheter inlet and the rest of the components. This cooling console was used to
circulate chilled saline (distilled water) at 10 ml/min to 90 ml/min through the catheter by
first chilling the distilled water to 0⁰ C. The chilled infusate is pumped from a small
reservoir to the catheter via a peristaltic pump (Watson-Marlow Fluid Technology Group,
Wilmington, MA). A thermoelectric chiller (Custom Chill Inc., Philadelphia, PA) and a
flat plate heat exchanger (GEA PHE Systems NA, York, PA) is used to chill the infusate
to the desired temperature, 0℃.
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Equipment
Various equipment was used for the mock loop system, including flow meters,
pressure sensors, thermocouples, pumps, fittings, and computer hardware. This section
describes the make and models, calibration ranges, and medical devices used in the mock
circulatory loop system.
Make and models. Table 4.4 lists the makes and models of the equipment used to
replicate and measure physiological conditions in the in vitro circulatory mock loop
system.

Table 4.4
Make and model of flow meters, thermocouples, and pressure transducer used in mock
circulatory loop system.
Description
Instrument
Make & Model
Turbine Flow Meter
McMillan Co., Georgetown,
Coronary Flow
TX, S/N 11744
Turbine Flow Meter
McMillan Co., Georgetown,
Core Flow
TX, S/N 1616
Type-T Thermocouples Physitemp, Clifton, NJ
Cath. Inlet & Outlet,
HX, ambient temp
Thermocouple
Omega, Norwalk, CT
Aorta (core) temp
Pressure
Transducer
Cole Parmer, Vernon Hills,
Aorta Pressure
IL, 68075-32
Note. Heat Exchanger = HX.

A description of the peristaltic pump, Tuohy Borst adapters, and full-size glass
aortic arch employed in the mock loop system are listed in Table 4.5.

45

Table 4.5
Make and model of peristaltic pumps, glass aorta, and Tuohy Borst adapters employed in
the mock circulatory loop.
Description
Instrument
Make & Model
Peristaltic Pump
Ismatec, Glattbrugg, Switzerland
Circulatory Pump
Peristaltic Pump
Watson-Marlow, Wilmington, MA
Infusate Pump
Custom Dampener FocalCool, LLC, Mullica Hill, NJ
In-Circuit
Dampener
Full-Size Glass
Vasodyn, Freeville, NY
Aortic Arch
Aorta
Tuohy Borst
Qosina, Ronkonkoma, NY, P/N
LMCA
Adapter w/Sideport 80460

The immersion heater used to heat the large reservoir (George Ulanet Co.
Newark, NJ) was controlled by a temperature feedback controller (Cole-Parmer, Vernon
Hills, IL) connected to a Thinkpad Ultrabook Intel core I5 vpro that was automated using
LabVIEW (National Instruments Co., Austin, TX) data acquisition (DAQ) software.
Range. Each thermocouple was calibrated to a confidence range that
corresponded to a specific physiological temperature local to its intended use. For
instance, the thermocouple for the aorta was calibrated for a confidence range between
35℃ and 38℃, which was used to measure core body temperature, 37℃. The confidence
ranges for each of the thermocouples are found in Table 4.6.

Table 4.6
Operational ranges for each thermocouple used in the mock loop system.
Thermocouples:
Range (℃)
Confidence Range (℃)
-1.0 - 15
-1.0 - 18
Cath Inlet Temp.
-1.0 - 15
-1.0 - 18
HX Outlet Temp.
15 - 25
17 - 28
Ambient Temp.
35 - 38
32 - 38
Aorta (core) Temp.
6.0 - 30
5.0 - 31
Cath Outlet Temp.
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Akin to the predetermined thermocouple ranges, the flow meters were also
calibrated to physiological flows and are listed in Table 4.7.

Table 4.7
Operational ranges for each instrument used to measure flow rate and pressure.
Flows:
Range
Confidence Range
3000 – 4000 ml/min 1000 – 4000 ml/min
Aorta
70 – 200 ml/min
82-183 ml/min
Coronary
Pressures:
Range
Confidence Range
0 – 30 psi
7-18 PSI
Catheter
Inlet
50 – 170 mmHg
25-156 mmHg
Aorta

Calibration and precision. Calibration methods were performed for the
thermocouples, flow meters, and pressure sensors. The thermocouples were calibrated in
a chilled liquid bath (Thermo NESLAB, Oak Park, IL) consisting of 50% glycerol and
50% distilled water so that 0℃ temperatures could be reached. Flow meters were
calibrated using gavimetric methods and pressure sensors were calibrated using known
water column heights. All sensor calibrations were within the manufacturer
specifications.
The tips of the thermocouples were positioned ~1.5 inches into the chiller bath
solution and the liquid bath ranged between -3℃ and 40℃ as LabVIEW was used to
record 60 temperature data points (1 point per second) for each thermocouple.
Each thermocouple was calibrated within a specific confidence range around its
working temperature in the mock loop system. A mock loop test calibration guide (Table
4.8) for the operational ranges for each thermocouple was created to keep track of each
thermocouple’s calibration parameters.
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Table 4.8
Thermocouple calibration ranges, calibration points & accuracy, and calibration check
method.
Thermocouples
Range
Calibration Points
Calibrated
Calibration
Accuracy
Check
(℃)
(℃)
(℃)
±0.28
Generated flow
Cath Inlet Temp -1.0 – 15 -3, 0, 3, 7, 12, 15, 20
vs voltage plot.
±0.55
HX Outlet Temp -1.0 – 15 -3, 0, 3, 7, 12, 15 ,20
Obtained linear
15 – 25 12, 15, 20, 23, 25, 30
±0.38
Ambient Temp
regression slope
35 – 40
30, 33, 35, 37, 40
±0.25
Aorta (core)
and y-intercept.
Temp
6.0 – 30
3, 7, 15, 23, 30, 33
±0.36
Cath Outlet

A linear regression and R2 value was determined for each thermocouple data set
to validate the accuracy of the calibration. The new slope and intercept value from each
thermocouple’s linear regression plot was added to the LabVIEW DAQ as a new
calibration input value.
The process for calibrating flow meters and pressure transducers was similar to
the thermocouple calibration method. A total of five calibration points were spread
evenly throughout the range of flows and pressures (Table 4.9) we intended to measure.
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Table 4.9
Coronary test calibration guide for the operational ranges for each instrument –
Continued.
Calibrated
Flows:
Range
Calibration Points
Calibration Check
Accuracy
± 200
Checked calibration
3000 – 4000
2000, 2500, 3000,
ml/min
– no recalibration
Aorta
ml/min
3500, 4000
necessary
Checked with water
70 – 200
60, 100, 130, 170,
± 1.04
weight of graduated
Coronary
ml/min
200
ml/min
cylinder divided by
time
Calibrated
Pressure:
Range
Calibration Points
Calibration Check
Accuracy
Checked with
Catheter
0 – 30 psi
0, 5, 10, 20, 30, 35
± 0.48 psig
hydraulic apparatus
Inlet
50 – 170
± 1.46
Checked with water
40, 80, 120, 140, 170
Aorta
mmHg
mmHg
column

After the data was recorded using LabVIEW, it was plotted in Excel and a new
slope was determined. A linear trend line was added to each graph, as well as the R2
value. An R2 value greater than 0.98 was considered satisfactory for the turbine flow
meter and pressure sensor calibrations. Coronary and aorta flow were calibrated with an
accuracy of ± 1.04 ml/min and ± 27 ml/min, respectively. The Aorta flow meter was
within the ± 200 ml/min acceptable limit for the calibration, therefore, no recalibration
was needed. The inputs, control variables, and outputs employed in the calibration
experiments are summarized as a flowchart in Figure 4.6.
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Thermocouple Calibration

Inputs

Parameters

Variables

Outputs

HX Out

-1 - 15 (℃)

N=7

±0.55

Ambient

15 - 25 (℃)

N=6

±0.38

Aorta

35 - 40 (℃)

N=5

±0.25

Cath In

-1 - 15 (℃)

N=7

±0.28

Cath Out

6 - 30 (℃)

N=6

±0.36

Flowrate Calibration

Inputs

Parameters

Variables

Outputs

Aorta

3000 - 4000 (ml/min)

N=5

±200 (ml/min)

Coronary

70 – 200 (ml/min)

N=5

±1.04 (ml/min)

Pressure Calibration

Inputs

Parameters

Variables

Outputs

Cath In

0 – 30 psi

N=6

±0.48 psig

Aorta

50 – 170 mmHg

N=5

±1.47 mmHg

Figure 4.6. Snapshot of the calibration design of experiments for thermocouple, flow, and
pressure calibration with each corresponding input, output, parameter, and variable.
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To calibrate infusate flow rates, the peristaltic pump in the cooling console varied
flow between 10 and 90 ml/min which was collected and measured in a graduated
cylinder. The calibrated measurements were updated in the DAQ system and are listed in
Table 4.10.

Table 4.10
Calibrated infusate flowrates exiting the guide extension from peristaltic pump in the
cooling console.
Description
Value
Units
Pump Flow Rate
10
20
30
50
70
90
9.08
19.3
29.20
49.0
68.8
88.9 ml/min
Calibrated Flowrate
0.03
0.1
0.08
0.2
0.2
0.4 ml/min
Total Uncertainty

The catheter inlet pressure and distilled water flow rates were measured using a
pressure transducer (PendoTech, Princeton, NJ) and a turbine flow meter (McMillan,
Georgetown, TX), respectively. The temperature and flow rate of the catheter was
monitored and controlled by the user with a computer running LABVIEW (National
Instruments Co., Austin, TX).
Medical devices. The medical devices used in this study (Table 4.11) comprised
of a 7F Cordis® guide and a 7F guide extension that was advanced through the guide to
the artery of interest.

Table 4.11
Make and model for each medical device used in the mock loop system.
Device
Model Description
7F Guiding Catheter

Cordis Vista BriteTip® (Part Number: JL 3.5)

7F GuideLiner® V3 Catheter

Vascular Solutions (Part Number: 5572)
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Results of In Vitro Studies
In this section we present the temperatures and flow rates at the guide inlet and
guide extension outlet, as well as the cooling capacity of the Cordis® guide for all
temperatures and flow rates used in the mock loop system. The term, infusate flow, will
be referred to in this section as the flow being pumped from the cooling console and
exiting the tip of the guide extension.
Temperatures. Aorta (core) temperatures were held constant at 37.07⁰ C ± 0.046
for all the mock loop trials. The Calibrated Infusate flow rates ranged between 9.08 and
88.9 ml/min (Table 4.12), and the temperatures for the heat exchanger outlet, catheter
inlet, and guide extension outlet were recorded.

Table 4.12
Various temperatures recorded from infusate flow rates ranging from 9.08 ml/min to 88.9
ml/min in the cooling console circuit.
Description
Units
Value
Calibrated Infusate
ml/min
9.08
19.27 29.2 49.03 68.85
88.9
Flow Rates
Heat Exchanger
1.83
1.34
1.1
0.92
0.91
0.83
⁰C
Outlet Temp
Catheter Inlet
8.205
4.78
3.52
2.46 2.087
1.76
⁰C
Temperature
Guide Extension
36.31 33.36 29.4 23.16 19.2
16.36
⁰C
Outlet Temperature

As seen in Table 4.8, infusate flows in the cooling console circuit retained cooler
temperatures with higher flowrates. To visualize this scene, temperatures entering the
Cordis® guide and exiting the guide extension tip were plotted (Fig. 4.7) against their
corresponding infusate flow rates.
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40.00
Guide Extension Exit
Temperature

35.00

Temperature (℃)

Guide Inlet Temperature

30.00
25.00
20.00
15.00
10.00
5.00
0.00
0.00

20.00

40.00

60.00

80.00

100.00

Flowrate (ml/min)
Figure 4.7. Temperatures entering the Cordis® guide and exiting the guide extension vs
infusate flow rates from mock loop cooling console. Increased infusate flowrates resulted
in lower fluid temperatures both entering and exiting the Cordis® guide and guide
extension, respectively. Infusate flowrates leaving the heat exchanger varied between
0.023℃ and 0.112℃. Standard. Note: standard deviation error bars are capped.

Flows. The cooling console circulated distilled water from a small reservoir into
the heat exchanger and was expelled as chilled fluid <1⁰ C before entering the guide.
Flow rates entering the Cordis® guide ranged between 9.08 and 88.9 ml/min (Table 4.13)
and resulted in varying catheter inlet and outlet temperatures.

Table 4.13
Standard deviation (SD) for flow rates, guide extension inlet temperature, and guide
extension outlet temperature.
Infusate Flow (ml/min)
Guide Inlet (⁰C)
Guide Extension Outlet (⁰C)
Flowrate
SD
Temperature SD
Temperature
SD
9.08
0.0289
8.205
0.0414
36.31
0.0521
19.27
0.1041
4.478
0.0555
33.36
0.3203
29.2
0.0866
3.52
0.0429
29.4
0.1881
49.03
0.2309
2.459
0.0321
23.16
0.1564
68.85
0.2179
2.087
0.0141
19.2
0.0944
88.9
0.3605
1.76
0.0376
16.36
0.1253
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Catheter inlet temperatures ranged between 1.76⁰ C and 8.205⁰ C with a standard
deviation ranging between 0.0141⁰ C and 0.0555⁰ C for all six inlet temperatures. The
temperatures exiting the guide extension ranged between 16.36⁰ C and 36.31⁰ C with a
standard deviation between 0.0944⁰ C and 0.3203⁰ C for all six guide extension outlet
temperatures.
Cooling capacity. Cooling capacity, 𝑄̇𝐼 , was calculated using data obtained from
the chilled infusate catheter flow rates and guide extension outlet temperatures using
equation 4.1:
𝑄̇𝐼 = 𝑚̇𝐼 𝑐𝑝 ∆𝑇𝐼

(4.1)

where 𝑄̇𝐼 is the heat capacity of the infusate in watts, 𝑚̇𝐼 is the mass flow rate of the
chilled infusate in kg s −1 , 𝑐𝑝 represents the specific heat of the chilled infusate in J
kg −1 C−1 , and ∆𝑇𝐼 represents the delta between the mock loop core temperature and the
guide extension outlet temperature in ℃. The characteristic values for 𝑚̇𝐼 , 𝑐𝑝 and ∆𝑇𝐼
were 1.513e-4 – 1.482e-3 kg s −1 , 4186 J kg −1 C−1 , and 0.72 – 20.7 ℃, respectively. The
resultant cooling capacity is listed for each infusate flow rate in Table 4.14.

Table 4.14
Data obtained for the infusate flow rates, guide extension outlet temperatures, and aorta
temperatures using Eq. 4.1 to solve for cooling capacity.
Infusate Flow
Guide
Cooling
Aorta (⁰C)
Delta (⁰C)
(ml/min)
Extension
Capacity (W)
Outlet (⁰C)
36.31 ± 0.052 37.028 ± 0.049 0.72 ± 0.10
0.45 ± 0.06
1 9.08 ± 0.029
4.93 ± 0.31
2 19.27 ± 0.104 33.36 ± 0.320 37.023 ± 0.078 3.67 ± 0.24
29.2
±
0.087
29.40
±
0.188
37.116
±
0.070
7.72
±
0.18
15.72
± 0.41
3
47.58 ± 0.57
4 49.03 ± 0.231 23.16 ± 0.156 37.068 ± 0.053 13.91 ± 0.12
85.65 ± 0.34
5 68.85 ± 0.218 19.20 ± 0.094 37.033 ± 0.080 17.83 ± 0.01
16.36 ± 0.125 37.061 ± 0.068 20.7 ± 0.06
128.41 ± 0.41
6 88.9 ± 0.360
Note. The ± values following each entry represent the standard deviation for three data
sets.
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It is worth noting from Table 4.10 that infusate flow in line 1 is approximately
one-tenth the value of the infusate flow in line 6, whereas corresponding cooling
capacities (Eq. 4.1) do not reflect this same ratio. Specific heat, 𝑐𝑝 , in Eq. 4.1 is constant,
thus cooling capacity must be contingent upon either mass flowrate, 𝑚̇𝐼 , or the change in
fluid temperature, ∆𝑇𝐼 . Since fluid temperature in line 6 is two orders of magnitude
greater than line 1, then the resultant cooling capacity ratios become significantly
dependent on the ∆𝑇𝐼 along the catheter rather than infusate flow, which varies only by
one order of magnitude.
By applying the data obtained for infusate flow and guide extension outlet
temperatures in Table 4.11, a plot can be generated (Fig. 4.8) to show cooling capacity as
a function of infusate flowrate and temperature.

GuideLiner® Outlet Temperature (℃)

Cordis 7F Cooling Capacity vs Temperature and Infusate
Flowrate
45.00
40.00
0.5

35.00

4.9

30.00

15.7

25.00

47.6

20.00

85.7
128.4

15.00
10.00
5.00
0.00
0.00

20.00

40.00

60.00

80.00

100.00

Infusate Flow Rate (ml/min)

Figure 4.8. Cordis® 7F guide cooling capacity for flowrate vs outlet temperature. Blue
circles represent the power (W) required to produce guide extension outlet temperatures
at corresponding flowrates.
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Summary and Connection to Computational Work
In summary, the distilled water exiting the guide extension resulted in
temperatures between 36.31⁰ C and 13.36⁰ C and volumetric flowrates ranging between
9.08 ml/min and 88.9 ml/min, respectively.
The minimum power required to cool infusate fluid to TH temperatures required a
minimum of 15.72 Watts, which yielded an outlet temperture of 29.4⁰ C. Although six
flowrates were analyed and tested in the mock loop system, only three were chosen for
the CFD simulations. The first three flowrates that exhibited TH temperatures were
chosen for the CFD simulations; 29.2 ml/min, 49.03 ml/min, and 68.85 ml/min.
The outlet temperatures and flow rates attained from this study were used as the
guide extension outlet conditions in the CFD modeling studies for all representative heart
(RH) models. The vascular differences between these RH models are discussed in detail
in Chapter 5.

56

Chapter 5
Representative Hearts (RH’s)
Source of Human Heart 3D Models
In 1997, the Visible Heart® Project was launched as a subsidiary medical division
to the University of Minnesota. In 2000, the free-access website, Atlas of Human Cardiac
Anatomy was launched from Visible Heart® to provide free images, videos, and CT/MRI
DICOM files to students, academia, and industry personnel [135]. As of 2016, Visible
Heart® has reanimated 75 human hearts and its Atlas website contains human cardiac
anatomy images from more than 400 human heart specimens. With permission from a
donor’s family, LifeSource, a non-profit organ donation company, donates hearts from
organ donors that have been considered non-viable for transplantation to the Visible
Heart® Laboratory (VHL) [135]. Computed tomography (CT) and magnetic resonance
(MR) imaging of the donated hearts are performed internally and uploaded in DICOM
format to the Atlas website.
Each human heart (HH) is numbered on the Atlas website and contains detailed
descriptions for each specimen’s gender, age, and cardiac medical history. VHL was an
excellent resource for attaining our high quality cardiac images that can also be used to
help guide the verification and development process of new therapeutic hypothermia
(TH) transcatheter therapies.
Rationale for selecting specific RH’s
The complex structure of cardiac anatomy plays a vital role in cardiac medical
device design and procedures [136][137]. Understanding anatomical variations in human
hearts is a critical factor for determining its impact on cardiovascular interventions
[138][139][140]. To better understand anatomical variations in left main coronary artery
(LMCA) networks and their impact on cardiovascular procedures, a collection of HH
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models were strategically selected for this study to represent a unique set of similar
patient-specific LMCA networks.
The rationale for choosing similar heart models was to apply “identical” CFD
boundary conditions and physics solvers to analyze the impact of each patient’s coronary
structural variations on heart cooling. Human hearts in the VHL database that expressed
similarities in LMCA anatomical networks were chosen for this work. The similarities
between each model were identified visually based on their vascular network and
included similarities in artery network patterns, vessel diameters, and vessel lengths.
Choosing hearts with large proximal left anterior descending (LAD) and left circumflex
(LCX) artery diameters was critical for accommodating the insertion of a GuideLiner®
(Fig. 5.1) in each proximal LAD and LCX artery.

Proximal LAD/LCX
Vascular Solutions GuideLiner®

5.0mm

Figure 5.1. Proximal LAD and LCX GuideLiner® insertion method. Large proximal
artery diameters are critical for accommodating and simulating GuideLiner® insertion.

For this study, we analyzed 33 patient-specific human hearts from the VHL
database. After careful consideration, we chose six human hearts that have no
abnormalities and most closely resemble normal LMCA geometries and anatomical
configurations. Each heart model (Fig. 5.2) contains varying branch lengths, vessel
diameters, and quantity of bifurcated branches in its network.
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HH55

LCX

HH88
LCX
LAD

LAD

HH97

LCX

LAD

HH178

HH102

LCX

LAD

LCX

HH259

LCX

LAD
LAD

Figure 5.2. Representative hearts (RH) that were chosen for this work. These RH’s were
created in Mimics® and were exported into STAR-CCM+ for CFD modeling. All RH
models contain a LMCA stem that bifurcates into an LAD and LCX artery.
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Heart Model Structural Comparison
Each heart model expressed vascular differences that varied in artery lengths,
diameters, and the number and location of bifurcations stemming from each artery
segment. Although 6 patient-specific hearts were chosen for this study, no two hearts
were anatomically identical.
Quantify differences between models. The aim of this section is to interpret the
vascular differences between all heart models and quantify these differences in terms of
length, area, and surface area to volume ratios. The goal is to link these quantitative
characteristics to temperature distribution data for each heart model so that assumptions
can be made regarding the impact of heart structure on cooling effectiveness.
Lengths. The proximal LAD and LCX is defined as the distance from its left main
bifurcation to the first major septal perforator [136][137][138][139][140], and the
distance from its left main bifurcation to the first obtuse marginal branch [6][8],
respectively.
The segment lengths of the LAD and LCX arteries varied with each HH model.
The length and average diameter for each proximal LAD and LCX model was measured
and recorded in Table 5.1.

Table 5.1
Length of proximal LAD and LCX arteries before major bifurcation.
Proximal LAD
Proximal LCX
Heart
Units
Length
AVG
Length
AVG
Model
Diam.
Diam.
mm
19.8
3.14
12.9
2.79
HH55
mm
31.7
4.12
12.4
3.55
HH88
mm
15
3.55
9.23
2.78
HH97
mm
12
2.91
28
2.44
HH102
mm
22.5
3.03
57.5
2.72
HH178
mm
25
3.08
29
3.45
HH259
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As seen in Table 5.1, HH102 had the shortest proximal LAD segment (12mm),
while HH88 had the longest proximal segment (31.7mm). Consequently, HH97 had the
shortest proximal LCX (9.23mm) and HH178 had the longest proximal LCX (57.5mm).
From these observations, LAD and LCX artery geometries and their anatomical network
structures are independent of each other (Fig. 5.3) and will need to be evaluated as
discrete LAD and LCX models.

HH55
Px

Pl

HH88

Pl

Px

Pl

HH102

HH97
Pl

HH178

HH259
Px

Pl

Px

Pl

Px

Px

Figure 5.3. The proximal segments of the LAD and LCX arteries highlighted in yellow.
Note: proximal LAD = Pl and proximal LCX = Px.

A comparison between the first obtuse marginal branches of the LCX for HH88,
HH178, and HH259 (Fig. 5.4) was made to compare the varying lengths of each proximal
segment.
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a.

b.
29mm

12.4mm

FOM 

FOM 

c.
57.5mm

FOM

Figure 5.4. Variations in proximal LCX artery lengths. The proximal LCX extends from
the left main bifurcation to the first obtuse marginal branch (FOM). HH88 (a) contains
the shortest proximal segment length, while HH259 (b) and HH178 (c) contain the
average and longest proximal segment lengths of all heart models chosen for this work,
respectively.

As described in Fig. 5.4, HH259’s proximal trunk is 124% longer than HH88’s,
while HH178’s proximal trunk is 363% longer than HH88. This further supports the
claim that no two patient-specific heart structures are alike, and that the total lengths of
each artery network (Table 5.2) will need to be considered for evaluating TH temperature
distributions in CFD post-processing.

Table 5.2
Total length of all vessels in each LAD and LCX structure.
Total LAD Vessel
Heart Model
Units
Lengths
mm
433.03
HH55
mm
297.7
HH88
mm
372.9
HH97
mm
157
HH102
mm
394.3
HH178
mm
429.7
HH259
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Total LCX Vessel
Lengths
465.5
316
269.03
286
359.13
373.1

Areas. The surface areas for each heart model were generated in SolidWorks
using the Mass Properties function. Surface areas are listed for each patient-specific LAD
and LCX model in Table 5.3.

Table 5.3
Overall surface area for each HH model.
Human Heart (HH)
Units
LAD Surface Area
2
mm
2404.87
HH55
mm2
2177.65
HH88
2
mm
1913.46
HH97
mm2
1030.87
HH102
2
mm
2377.44
HH178
mm2
2227.59
HH259

LCX Surface Area
4105.07
1752.51
1590.99
1613.86
1937.45
2215.9

The smallest LAD artery surface area was HH102. HH55’s LAD and LCX
arteries both dominated in surface area compared to the rest of the heart models, resulting
in 2404.87 mm2 and 4105.07 mm2, respectively. The surface area for each LAD and LCX
heart model was described by a quantitative plot (Fig 5.5) so that a comparison between
surface areas could be made for all RHs.
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4500

Surface Area (mm2)

4000
3500
3000
2500
2000
1500
1000
500
0
HH55

HH88

HH97
LAD

HH102

HH178

HH259

LCX

Figure 5.5. Quantitative plot showing the comparison between surface area and all LAD
and LCX representative heart (RH) models.

Volumes. Like the surface area comparison in Fig. 5.5, a volume comparison
between all LAD and LCX RH models were plotted together (Fig. 5.6) so that a
quantitative comparison could be observed.

2500

Volume (mm3)

2000

1500

1000

500

0
HH55

HH88

HH97
LAD

HH102

HH178

HH259

LCX

Figure 5.6. Quantitative plot showing the comparison between volume and all LAD and
LCX representative heart (RH) models.
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Surface area to volume ratios. The surface area to volume ratios for the LAD and
LCX models compare the size of each artery’s surface area to the volume inside each
artery’s network. Surface area to volume ratios (SA:V) were calculated for all LAD and
LCX artery models (Table 5.4).

Table 5.4
Surface Area to Volume ratios for each LAD and LCX model employed in the study.
HH55
HH88
HH97
HH102
HH178
HH259 Units
LAD 2.368528 1.727352 2.35666 2.53667 2.747695 2.767548 m-1
LCX 1.986149 2.218433 2.406192 2.087923 2.35993 2.152103 m-1

The surface area and volume of each representative heart model was calculated
using the Mass Properties tool in SolidWorks®. The accuracy of each SA:V ratio could
be impacted by the guide extension insertion depth in each proximal artery, which ranges
from 3-5mm. However, SA:V ratio accuracy could be improved if higher resolution
DICOM images were created in Mimics. This would allow us to locate more bifurcations
and extend each vessel down to the capillaries (or as close as possible).
High SA:V ratios are typically a result of low volume objects that exhibit large
surface areas [141], which could indicate long, thin artery networks in our HH models
(Fig. 5.7).
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Surface Area to Volume Ratio
(mm-1)
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2
1.5
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0.5
0
HH55

HH88

HH97
LAD

HH102

HH178

HH259

LCX

Figure 5.7. Surface area to volume ratios between all LAD and LCX representative heart
(RH) models.

Suppose the volume (amount of space) inside an artery network were to grow.
The surface area surrounding the volume of this artery network would increase as well
[142]. Surface area to volume (SA:V) ratios in cylinders can be simplified
mathematically to 2/R, where R is the radius of the cylinder. Therefore, when volume
increases, the SA:V ratio decreases, and vice versa.
Fig. 5.6 shows a visual representation for each heart model and its corresponding
surface area to volume ratio. HH259 has almost identical surface area values for both its
LAD and LCX arteries, however, since its LAD has a slightly lower volume to that of its
LCX, the surface area to volume ratio is larger for its LAD network. This suggests the
possibility that the LAD for HH259 has smaller and longer vessels than its LCX
counterpart network.
The rationale for choosing the RH models in this study was to execute identical
interventional CFD simulations and compare the outcomes of all models to reveal the

66

impact of vascular structure on cooling impact. Human heart artery lengths, diameters,
and SA:V ratios will be used to explore CFD simulation results in succeeding chapters.
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Chapter 6
Thermal Fluid Model Setup for RHs
Now that we have established the biophysics background (Ch. 2), described the
computational methods (Ch. 3), and introduced the representative heart models (Ch. 5),
we will now describe the steps required to solve thermal fluid flow through each of the
left main coronary artery (LMCA) networks.
Geometries
Patient-specific left main coronary artery (LMCA) geometries impact medical
device performance. We characterized each artery’s network by identifying four main
branches in the left anterior descending (LAD) artery, and three main branches in the left
circumflex (LCX) artery (Fig. 6.1).

a.

1DB

SB

b.
Plb
2om
1om

AD

2DB

Figure 6.1. Ideal LAD (a) and LCX (b) networks [143]. Note for the LAD (a): first
diagonal branch (1DB), second diagonal branch (2DB), septal branches (SB), and
anterior descending (AD). Note for the LCX: first obtuse marginal branch (1om), second
obtuse marginal branch (2om), and posterolateral branch (Plb).
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We identified four main branches that characterized each LAD model [143]; first
diagonal branch, second diagonal branch, septal branches, and the anterior descending
branch. Similarly, we identified three main branches that characterized each LCX model
[143]; first obtuse marginal and second obtuse marginal branches, and the posterolateral
branch. Lastly, it was important to understand the geometry of the 7F Cordis® guide
catheter and GuideLiner® used in the in vitro mock loop system. The OD and ID of the
GuideLiner® tip (Fig. 6.2) was implemented as a modeling parameter in the proximal
LAD and LCX arteries.

GuideLiner® Boundaries

1.57mm
1.9mm
3-5mm
Figure 6.2. Isometric view of a general representation of the OD and ID of the
GuideLiner® in a straight tube describing the GuideLiner® boundaries for each proximal
artery. The depth of the insertion varied between 3-5mm and the OD and ID were fixed at
1.9mm and 1.57mm, respectively.

Physiological geometry. Each of the six heart models that were chosen for this
study were broken down into the LAD and LCX artery networks. The LAD (Figure 6.3)
and LCX (Figure 6.4) networks of each patient-specific heart were grouped together so
that similarities and differences could be identified between the two groups.
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1DB
1DB

SB

SB
2DB

SB
2DB

AD
AD

AD

2DB

a.

b.

c.
1DB

SB

1DB
1DB

SB

AD

2DB
d.

e.

f.

Figure 6.3. Patient-specific LAD networks for HH55, HH88, HH97, HH102, HH178, and
HH259, for hearts a. through f., respectively. Note: first diagonal branch = 1DB, second
diagonal branch = 2DB, septal branches = SB, and the anterior descending branch = AD.
HH88 had no identifiable septal perforator branch (b), which could have been attributed
to poor image quality in the DICOM file format.
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Plb
Plb
2om
2om

1om

1om

a.

b.

2om
1om
Plb

1om

3om

Plb

2om

c.

d.

1om
2om

1om

Plb
2om

Plb

e.
f.
Figure 6.4. Patient-specific LCX networks for HH55 (a), HH88 (b), HH97 (c), HH102
(d), HH178 (e), and HH259 (f). Note: the first obtuse marginal branch = 1om, second
obtuse marginal = 2om, and the posterolateral branch = Plb. HH97 appears to have a third
obtuse marginal branch (c) that extends between the second obtuse marginal and the
posterolateral branches [144].
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It is important to acknowledge that not all vascular features can be easily
resolved. Heart model HH88 LAD had no identifiable septal perforator branch, which
could be a result of 1) poor DICOM image quality that was not able to recognize the
bifurcation during Mimics® segmentation, or 2) VHL’s CT angiogram imaging method
did not fully capture the septal perforator branch in the DICOM file. The remaining HH
models had identifiable branches that enabled us to characterize the anatomical
differences between each model.
Medical device geometry. Both the 7F guiding catheter and the 7F GuideLiner®
were used in the mock loop system. To insert these devices into the circulatory mock
loop system (Ch. 4), a guide wire was inserted into the proximal hub of the mock loop’s
femoral artery and advanced through the aorta, where it was steered and exited the left
main coronary artery (LMCA). Next, the guide catheter was inserted over the guide wire
and advanced to the ostia of the LMCA. The guide catheter was fixed at the LMCA
ostium and a GuideLiner® was inserted through the guide catheter and advanced 8.5cm
out of the catheter outlet.
Although both devices were used in the mock loop study, only 3-5mm of the
GuideLiner® tip was modeled and used in the CFD simulations. A description and list of
dimensions for each device are listed in Table 6.1.

Table 6.1
Descriptive parameters for each medical device used in the mock loop system.
Device
Location
Value
Device Length
ID
1.98mm
100cm long
7F Guiding Catheter (0.078”
ID)
OD
2.3mm
ID
1.57mm
150cm long
7F GuideLiner® V3 Catheter
OD
1.9mm
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As seen in Table 6.1, the GuideLiner® is 50% longer than the guide catheter so
that it can be inserted and advanced out of the guide catheter. Clearance between the
GuideLiner® OD wall and the guide catheter ID wall was 0.08mm.
To make the inlet geometry as reasonable as possible, we chose to implement an
eccentric inlet geometry for each HH model. Since eccentric GuideLiner® placements
were evident in the mock circulatory loop (Ch. 4), we can assume that the same
phenomenon holds true in a clinical setting. Therefore, to retain consistency, an eccentric
GuideLiner® insertion was assumed lining the anterior side of the coronary artery for all
CFD simulations. A general representation for the GuideLiner® inlet geometry in the
proximal LAD and LCX (Fig. 6.5) vascular network.

Eccentric
Region

Mixing
Region

Blood Flow
3-5 mm Insertion

LMCA ID

GuideLiner®
Flow
1.90 mm OD

1.57 mm ID

Figure 6.5. Sagittal view of a general representation of the inlet geometry and boundaries
describing the GuideLiner® placed in each proximal LMCA. The depth of the insertion
varied between 3-5mm and the OD and ID were fixed at 1.9mm and 1.57mm,
respectively.

It would be unreasonable to assume that physicians achieve consistent eccentric
placement of the GuideLiner® in each proximal LAD and LCX artery in a clinical
setting. If however, perfect concentricity could be achieved during intracoronary
operations, such that the GuideLiner® could be place at a non-normal angle with respect
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to the arterial cross-section, then temperature distribution results would undeniably be
changed. Therefore, to retain consistency in our CFD simulations, an eccentric
GuideLiner® insertion lining the anterior side of the artery was assumed for all CFD
cases.
Physics
Prior to executing a CFD model, physics conditions need to be determined so that
STAR-CCM+, the finite volume method solver, can apply the correct governing
equations. Table 6.2 describes a list of parameters used for the physics conditions in each
of our CFD models.

Table 6.2
Physics conditions used for each CFD heart model in STAR-CCM+.
Parameter
Value
Description
Three Dimensional
x, y, and z coordinate space
Space
Steady
T = constant. Results
Time
represent a single point in
time.
Liquid
--Material
Segregated Flow
Continuity, momentum, and
Flow
energy are solved
sequentially (segregated from
each other).
Constant Density
Incompressible fluid
Equation of State
Laminar
Re < 2300
Viscous Regime
Segregated Fluid Temperature Entire energy equation is
Solver
solved with T as independent
variable. Enthalpy is then
calculated from temperature
as stated by the equation of
state.
Note. Re = Reynolds number, T = Temperature.
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Governing equations. As discussed in Chapter 2, the Navier-Stokes equations for
conservation of linear momentum (Eq. 2.4a), the continuity equation of conservation of
mass (Eq. 2.5), and the conservation of thermal energy (Eq. 2.7), govern the fluid
dynamics of flow and thermal energy in a physics domain.
𝑑𝑉

𝜕𝑇

𝜌 𝑑𝑡 = 𝜌𝑔 − 𝛻𝑝 + 𝜇 · 𝛻 2 𝑉

(2.4a)

𝛻 · 𝑉=0

(2.5)

𝜕𝑇

𝜕2 𝑇

𝜕𝑇

𝜕2 𝑇

𝜕2 𝑇

𝜌𝐶𝑝 [𝑢 𝜕𝑥 + 𝑣 𝜕𝑦 + 𝑤 𝜕𝑧 ] = 𝑘 [𝜕𝑥 2 ] + 𝑘 [𝜕𝑦 2 ] + 𝑘 [𝜕𝑧 2 ]

(2.7)

where Eq. 2.7 is coupled with Eq. 2.4a because the viscosity, 𝜇(𝑇) is a function of
temperature, where T is determined from Eq. 2.7. The coupling is performed so that
viscosity can be solved as a function of temperature, 𝜇(𝑇).
Boundary conditions. Equations 2.4a and 2.5 are applied as the governing
equations necessary to solve fluid pressure and velocity fields in the coronary arteries. To
solve these equations for flow field properties, appropriate boundary conditions will need
to be fixed. The boundary conditions implemented in each heart simulation are described
in Figure 6.6.
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Inlet: Blood Flow / 𝑇𝑖𝑛
No-Slip / Isothermal Walls

Inlet: GuideLiner® Flow / 𝑇𝑖𝑛
Outlets: Pressure = 0 Pa /

𝜕𝑇
𝜕𝑠

=0

Outlets Continued

Figure 6.6. HH55 LAD Navier Stokes and thermal energy boundary conditions applied to
all patient-specific RH models. Identical boundary conditions were applied to each of the
remaining LAD and LCX artery models. Each heart model exhibits a single blood flow
inlet and GuideLiner® flow inlet. The number of outlets for each heart model varied and
ranged from 7 outlets for HH88 LAD to 33 outlets for HH55 LCX. Navier-Stokes
description is designated to left of comment (slash), while thermal energy is represented
to the right.

For this study, six patient-specific hearts were chosen and prepared for CFD
modeling. The LMCA for each heart was modeled and segmented into six LADs and six
LCXs. Each of the 12 patient-specific heart models represent the blood domain of the
LAD and LCX and excludes the vascular wall and tissue domain. Each heart model
represents patient-specific asymmetric artery networks with rigid, no-slip boundary
conditions at the walls, where velocity is zero.
The outlets were assumed to a constant pressure of 0.0 pascal. The inlets used a
mass flow inlet condition that represented both the blood flow and chilled GuideLiner®
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flow entering the artery. Although blood flow is pulsatile in nature and GuideLiner®
flow is steady, a steady state laminar blood and GuideLiner® flow rate was assumed.
Blood will be considered as an incompressible, Newtonian fluid, as described in Chapter
2. Dynamic viscosity and its shear-thinning correlation will be discussed in greater detail
later in this chapter.
To simulate therapeutic hypothermia (TH) in the blood domain, a catheter is
typically inserted into the femoral artery and advanced into the coronary ostia. A
GuideLiner® is advanced out of the catheter and into the proximal artery (Fig. 6.7) where
cooled infusate is delivered and mixed with blood flow.

Figure 6.7. Eccentric GuideLiner® catheter in the proximal HH55 LAD representing two
distinct inlets for the GuideLiner® and blood flow. Inlet flow conditions for the blood
and GuideLiner® lead to assumed complete mixing solution of blood and distilled water.

In vivo blood flow rates entering the proximal LAD and LCX arteries have been
determined using methods involving lumped parameter modeling of computed
tomography (CT) scans [9], 3-dimensional epicardium simulations [10], ultrasound [11],
and phase contrast magnetic resonance imaging (MRI) [12]. As a result, average blood
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flow in the LMCA is estimated between 29.06 mL/min and 90.6 mL/min [9][12]. Thus,
based on these findings, we chose a distinctive total inlet flow rate of 75 mL/min (Fig.
6.8) for all of our simulations.

Bao, 2018 (CT & LPM)
Kim, 2010 (3D Epicardium Sim.)
Thesis Work (75 mL/min)
Wieneke, 2004 (Ultrasound)
Johnson, 2008 (PC-MRI)
DP

SEP

DP

Time (s)

Figure 6.8. Average left coronary artery blood flow as determined in literature using
various methods involving lumped parameter modeling, 3D epicardium simulations,
ultrasound, and phase contrast MRI. Based on these published findings, a total inlet flow
rate of 75 mL/min was chosen for all of our CFD simulations.

Where the total inlet flow rate of 75 mL/min is independent of blood and
GuideLiner® flow rates (Fig. 6.9), and remain a constant parameter for all CFD
simulations.

GuideLiner® Flow
75 mL/min Total Flow
Blood Flow

Figure 6.9. Total inlet flow rate representing GuideLiner® and blood flow entering each
proximal LAD and LCX artery network.
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Boundary conditions are an important pre-processing step to solving any CFD
model. Once boundary conditions are fixed, they govern the domain and boundaries of
the model and set the stage for executing the CFD solvers. Table 6.3 lists detailed
boundary conditions that were applied to each heart model simulation in STAR-CCM+.

Table 6.3
Boundary conditions and equations applied to each human heart model in STAR-CCM+.
The inlet conditions represent the final three flow rates used in the CFD simulations.
Boundary Condition
Navier-Stokes
Thermal Energy
References
Blood In
6.15 ml/min 37°C
[4], See Chapter
45.8 ml/min
4 – Results
GuideLiner® In
29.2 ml/min 29.4°C – 19.2°C
See Chapter 4 68.85 ml/min
Results
δT
Out
P = 0 Pa
[145]
=0
δs
Wall
Velocity = 0
[13]
37℃

We assume that the rate of change of temperature along the vessels approaches
zero at the vascular outlets, therefore

𝛿𝑇
𝛿𝑠

= 0. As the purpose of this study is to examine

temperature distributions in patient-specific LAD and LCX arteries, setting the wall
temperature to isothermal is an expedient assumption for this study. The expectation of
impending tissue cooling studies is that wall-coupled heat transfer exists in real life
applications and should be implemented in future studies to improve model fidelity.
Properties
We used mixture properties of blood and distilled water (infusate), after the two
fluids mixed (Fig. 6.10), as inlet conditions for the CFD models.
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Blood (𝑇 = 37℃)

Mixed Blood
Mixed Infusate

Heating Chamber
(𝑇 = 37℃)
Proximal LCX Inlet

Distilled
Water
(𝑇 = 𝑎, 𝑏, 𝑐)

HH102 LCX

Mixing Chamber
Cooling Chamber
(𝑇 = 𝑎, 𝑏, 𝑐)

Figure 6.10. Theoretical description of how mixture properties for blood and distilled
water were determined for the CFD inlet boundary conditions. 𝑇 = 𝑎, 𝑏, 𝑐 represents the
guide extension inlet temperatures 29.4, 23.16, and 19.2°C with corresponding flow rates
29.2, 49.03, 68.85 ml/min, respectively. Blood and distilled water was mixed at 𝑇 =
𝑎, 𝑏, 𝑐 guide extension infusate temperatures, and new mixed blood and infusate
properties were used as inlet conditions for the CFD models.

The blood and distilled water flow through the guide extension entering the
proximal end of the artery represents a mixture of the two. However, although both fluids
have the same properties after mixing, the mixed infusate fluid will be entering the guide
extension inlet at temperatures (a, b, c) (Fig. 6.10), while the mixed blood fluid will be
entering the blood flow inlet at 37°C. Since we assume complete mixing happens
immediately beyond the inlet, a limitation to this approach will be that the properties
down-stream are not experiencing perfect mixing. This will be discussed further in
Chapter 7. The three GuideLiner® flowrates and corresponding temperatures used in the
CFD simulations were determined from Chapter 4 – In Vitro Methods.
Density. To determine the final mixture property for density after the two fluids
mixed, the following linear mixing model (Eq. 6.1) was used:
1

𝜌𝑚 = 𝑚̇ (𝑚̇𝐼 𝜌𝐼 + 𝑚̇𝐵 𝜌𝐵 )
𝑇
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(6.1)

𝑘𝑔

𝑘𝑔

where 𝜌𝑚 is the mixed density (𝑚3 ), 𝑚̇𝐼 is the infusate mass flow rate ( 𝑠 ), 𝑚̇ 𝑇 is the
𝑘𝑔

𝑘𝑔

total mass blood flow ( 𝑠 ) into the artery, 𝑚̇𝐵 is the blood mass flow rate ( 𝑠 ), and 𝜌𝐼
𝑘𝑔

and 𝜌𝐵 are the infusate and blood density (𝑚3 ), respectively.
Thermal conductivity. To determine the mixture thermal conductivity after the
two fluids mixed, a second linear mixing model (Eq. 6.2) was used:
1

𝑘𝑚 = 𝑚̇ (𝑚̇𝐼 𝑘𝐼 + 𝑚̇𝐵 𝑘𝐵 )
𝑇

(6.2)

𝑊

where 𝑘𝑚 is the mixed thermal conductivity (𝑚⋅𝐾), and 𝑘𝐼 and 𝑘𝐵 is the thermal
𝑊

conductivity of the infusate and blood (𝑚⋅𝐾 ), respectively.
Specific heat. To determine the mixture specific heat after the two fluids mixed,
Eq. 6.3 was used:
1

𝑐𝑝,𝑚 = 𝑚̇ (𝑚̇𝐼 𝑐𝑝,𝐼 + 𝑚̇𝐵 𝑐𝑝,𝐵 )
𝑇

(6.3)

𝐽

where 𝑐𝑝,𝑚 is the mixed specific heat (𝑘𝑔⋅𝐾 ), 𝑐𝑝,𝐼 and 𝑐𝑝,𝐵 is the specific heat of the
𝐽

infusate and blood (𝑘𝑔⋅𝐾), respectively.
To determine the final mixture property for the temperature after the two fluids
mixed, the temperature and specific heat for both fluids, as well as all three flowrates
employed in the study were required to solve equation Eq. 6.4.
𝑇𝑚 =

(𝑚̇𝐼 ⋅𝑐𝑝,𝐼 ⋅𝑇𝐼 )+(𝑚̇𝐵 ⋅𝑐𝑝,𝐵 ⋅𝑇𝐵 )
𝑚̇𝑇 ⋅𝑐𝑝,𝑚

(6.4)

where 𝑇𝑚 is the mixed temperature(℃), and 𝑇𝐼 and 𝑇𝐵 is the temperature of the infusate
and blood(℃), respectively. The mixed temperature 𝑇𝑚 is used as a parameter to solve
for the dynamic viscosity.
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Dynamic viscosity. To determine the dynamic viscosity, Eq. 2.11 from Chapter 2
was used to determine the dynamic viscosity as a function of mixed temperature 𝑇𝑚 (℃),
1

shear rate Υ (𝑠 ), and hematocrit (Hct (%)) for each infusate flow rate [123].
𝜆

ϕ

µ(Υ, Hct, 𝑇𝑚 ) = (𝑒 Υ+ƞ⋅𝐻𝑐𝑡 )[𝛼 + (1+𝑒 𝛽(𝑇−Є))]

(2.11)

Therefore, the shear rate, hematocrit, and temperature are independent variables
and the dynamic viscosity is the dependent variable for this solution. Please see Appendix
B for a description of how viscosity is entered as a function of temperature in STARCCM+.
Property summary. Key properties are density (𝜌), specific heat (𝑐𝑝 ), thermal
conductivity (k), and dynamic viscosity (µ), as shown in the governing equations (Eq.
2.11 and Eq. 6.1 to 6.4). The material properties for both blood and distilled water are
temperature dependent and are listed in Table 6.4.

Table 6.4
Material properties for blood and distilled water entering the proximal LAD and LCX
[146][147][148].
Material Property
Units
Blood
Distilled Water
Density (𝝆)

kg/m3

1060

1006

Specific Heat (𝒄𝒑 )

J/kg-K

3560

4180

Thermal Conductivity (k)

W/m-K

0.52

0.598 to 0.614

(at 37℃)

(at 19.2℃ to 29.4℃)

Blood properties were determined from literature [130][140] assuming whole
blood, meaning plasma plus red blood cells at 37℃, while the distilled water properties
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were determined from the in vitro GuideLiner® infusion temperatures ranging between
19.2℃ and 29.4℃.
The blood and GuideLiner® inlet conditions in each CFD model represent blood
properties from literature combined with the in vitro circulatory loop distilled water
properties. These two fluids experienced different flow rates and temperatures
undergoing developing flow in the proximal artery network. Density and specific heat
were assumed to be dependent on the blood and distilled water material property only,
rather than temperature, since blood and distilled water were assumed to be mixed having
combined thermal-fluid properties. Table 6.5 summarizes the mixed material properties
used in our thermal fluid models.

Table 6.5
Blood and distilled water mixed fluid properties at variable GuideLiner® flow rates.
Material Property
Units
Mixed
Mixed
Mixed
Fluid1
Fluid2
Fluid3
3
kg/m
1010.43
1024.7
1038.98
Density (𝝆)
J/kg-K
4129.16
3965.31
3801.39
Specific Heat (𝒄𝒑 )
0.5916
0.5723
0.5566
Thermal Conductivity (k) W/m-K
Pa-s
0.00358
0.00205
0.00180
Dynamic Viscosity (μ)
1/s
2060.66
Shear Rate (𝜰)
20.4584
27.4625
33.7464
Mixed Temperature (T)
℃
Note. Mixed fluids 1, 2, and 3, correspond to GuideLiner® flow rates 68.85 ml/min,
49.03 ml/min, and 29.2 ml/min, respectively.

The material properties employed in the CFD model, specifically density, specific
heat and thermal conductivity, were calculated as a mixture assuming perfect mixing of
the blood and distilled water. The resulting mixed fluid properties were established as the
primary fluids entering as blood flow and GuideLiner® inlet conditions in each CFD
simulation.
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Dynamic viscosity is the only property dependent on temperature, hematocrit, and
shear rate, as seen in Eq. 2.11. The remaining mixed properties such as density (𝜌𝑚 ),
specific heat (𝑐𝑝,𝑚 ), and thermal conductivity (𝑘𝑚 ) are dependent on flow rate, as seen
in equations 6.1 to 6.3. Blood and GuideLiner® inlet temperature conditions were
assumed to be mixed (Fig. 6.10) and employed as inlet conditions for each thermal fluid
model. Mixed temperature conditions were dependent on specific heat of both fluids,
blood flow rate, and each of the three GuideLiner® inlet flow rates. The key property
assumptions for each fluid are described in Table 6.6.

Table 6.6
Key properties and assumptions for each mixed fluid.
Property
Assumption
Density
Temperature independent & flow rate dependent
Specific Heat
Temperature independent & flow rate dependent
Thermal Conductivity Temperature dependent
Mixed Temperature
Flow rate & specific heat dependent
Dynamic Viscosity
Temperature, Hematocrit, and Shear Rate dependent

In summary, the in vitro mock circulatory loop contained distilled water only. The
fluid properties for each corresponding GuideLiner® flow rate were calculated from the
in vitro mock circulatory loop and the blood plasma properties were determined from
literature (see Table 6.4). The material properties and corresponding assumptions (Table
6.6) for the blood and distilled water were combined to determine mixed fluid properties
that were used as inlet conditions in each CFD simulation.
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Post Processing
Mesh convergence. A mesh convergence analysis, as described in Chapter 3, was
performed for each of the 6 LAD and 6 LCX models to determine an appropriate mesh
density. The mesh density was determined by setting various base sizes in STAR-CCM+.
Base sizes in STAR-CCM+ are values that enable ratios to exist between boundary
conditions and the physics solvers. If the base size is a large value, the mesh will be
coarse, and the physics solvers will not compute an accurate solution. On the other hand,
if the base size is a small value, the mesh will be generated as a fine mesh and will yield a
more accurate solution, albeit, with greater computational expense.
For all models, a polyhedral mesh was generated using 3 prism layers (Fig. 6.11),
which generated a layered mesh at each wall boundary.

a.

b.

Figure 6.11. A close-up of the cells that encompass the polyhedral mesh (a) and a closeup of the 3 prism layers formed at each wall boundary (b). The prism layers are fixed at
the fluid-artery wall interface so that no-slip wall boundary conditions could be
accurately solved.

The prism layered mesh at the wall boundaries ensured that physics being solved
near the walls were solved with sufficient accuracy.
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The mesh density and mesh size are discretization parameters that must be
determined to yield accurate solutions in CFD modeling. The mesh quality in this study
will be defined by the number of cells in the model. Table 6.7 lists the number of cells
associated with three arbitrary heart models, as well as the time required to compute each
mesh using two different computing hardware.

Table 6.7
Three LAD and LCX models chosen at random and their associated mesh quality and
computational time using two discrete computing hardware.
Mesh Conversion
Mesh Quality
Time
Human Heart Model
Base Size
(Number of Cells)
WS1
WS2
0.00015 m
799,705
2.86 min
--HH88 (LAD)
0.00015 m
599,609
3.37 min
--HH88 (LCX)
0.00015 m
655,940
2.69 min
7.34 min
HH97 (LAD)
0.00015 m
535,340
3.14 min
--HH97 (LCX)
0.00015 m
812,517
4.51 min
8.81 min
HH178 (LAD)
0.00015 m
677,797
4.22 min
--HH178 (LCX)
Note. WS1 and WS2 are workstations 1 and 2, respectively, comprising of different
computer hardware. Details on the specifications of WS1 and WS2 computer hardware
are listed in Chapter 3.

A mesh convergence study was executed for all artery models using a best
practice convergence tolerance residual level of 1 x 10-4 [106] for each of the steady state
physics simulations. All LAD and LCX meshes contained approximately 8x105 cells
which was sufficient for executing the CFD solvers in the blood domain.
The mesh for HH97 LAD was executed using WS1 and resulted in a volume
meshing speed of 2.69 minutes (Table 6.7). In contrast, when the same operation was
performed using WS2, the volume meshing speed was deferred to 7.34 minutes. WS1
was generally 2x faster at computing volume meshes compared to WS2, and was used as
the primary machine to execute all computationally demanding mesh convergence
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analyses and STAR-CCM+ simulation runs. Table 6.8 illustrates the cell count for each
of the simulated LAD and LCX models.

Table 6.8.
Cell count and corresponding work station for each LAD and LCX model executed.
Model # Location Base Size
Cell #
WorkStation
LAD
823,707
WS1
HH55
0.00015 m
LCX
940,164
WS1
LAD
799,705
WS2
HH88
0.00015 m
LCX
599.609
WS2
LAD
655,940
WS2
HH97
0.00015 m
LCX
535,340
WS2
LAD
343,759
WS1
HH102
0.00015 m
LCX
911,245
WS1
LAD
812,517
WS1
HH178
0.00015 m
LCX
677,797
WS1
LAD
1,534,272
WS2
HH259
0.00015 m
LCX
1,251,094
WS2
Note. WorkStation represents the machine that was used to solve each HH simulation
using STAR-CCM+.

The optimum base size of 0.00015m used across all models was determined using
a mesh convergence analysis executed for the HH178 LAD (Fig. 6.12) and HH88 LCX
(Fig. 6.13).
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a. 37
35

Temperature (°C)

Optimum # of Cells
33
31
29
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25
23
0.0E+00

5.0E+05

1.0E+06

1.5E+06

2.0E+06

2.5E+06

Number of Cells in Mesh
c.

b.
Mesh Cells

CSP

Figure 6.12. A total of six base sizes were chosen for each heart model and the resultant
number of cells were plotted against the ABT (a) at a cross sectional plane (CSP) (c) in
the artery network. A proximal mesh view (b) shows the cells lining the surface of the
HH178 LAD model. A base size of 0.00015 m resulted in a reasonable number of cells
(~8e5) that led to invariant average bulk temperature at the CSP.
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a. 37

Temperature (°C)

35
Optimum # of Cells
33
31
29
27
25
23
0.0E+00

5.0E+05

1.0E+06

1.5E+06

2.0E+06

Number of Cells in Mesh
b.

c.
CSP

Mesh Cells

Figure 6.13. Six base sizes were chosen for heart HH88 LCX and the resultant number of
cells were plotted against the ABT (a) at a cross sectional plane (CSP) (b). A proximal
mesh view (b) shows the cells lining the surface of the HH88 LCX model. A base size of
0.00015 m also produced a mesh with (~6e5) cells that yielded sufficient ABT results.

The red triangle in Figs. 6.12a and 6.13a present a reasonable base size (1.5e-4 m)
to be used for determining accurate ABT’s for all the models balancing solution accuracy
vs computational cost. Optimal mesh size was chosen based on temperatures that were
measurable and clinically relevant in the real world. In this case, thermocouples
measuring GuideLiner® outlet temperatures (Table 4.6 in chapter 4) were calibrated to an
accuracy of ±0.36°C. As a result, over half a million cells were reduced using a base size
of 1.5e-4 m in most models, rather than 1.5e-4 m, since the ABTs between the two mesh
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sizes varied within the thermocouples calibrated accuracy of ±0.36°C. The remaining HH
mesh analysis studies were satisfactory since a tolerance of 0.5℃ was deemed acceptable
for this study and ABTs remained within ±0.36°C at the GuideLiner® outlet.
Thermal Fluid Model Testing Matrix
A thermal fluid modeling matrix was created to explore all six patients. Each of
the six LAD and LCX heart models required a total inlet flow rate of 75 mL/min (Fig.
6.9) that was independent of GuideLiner® and blood flow rate (Table 6.3), which
resulted in 36 total CFD models that needed to be organized and modeled correctly.
Therefore, the thermal fluid model testing matrix (Table 6.9) was a critical component for
the organization of this thesis work.

Table 6.9
Thermal fluid model testing matrix used to describe the catheter type, location, inlet
conditions, and models used in this thesis work. Please see Appendix C for a more
comprehensive version of the thermal fluid modeling matrix.
7F Cordis® Guide Catheter & GuideLiner®
HH55
Location
Flow Rate (ml/min)
Model #
(Proximal)
GuideLiner®
Total
Blood
LAD
75
45.8
29.20
HH55_1
25.97
49.03
HH55_2
6.15
68.85
HH55_3
LCX
75
45.8
29.20
HH55_4
25.97
49.03
HH55_5
6.15
68.85
HH55_6
HH88
Location
Flow Rate (ml/min)
Model #
(Proximal)
GuideLiner®
Total
Blood
LAD
75
45.8
29.20
HH88_1
25.97
49.03
HH88_2
6.15
68.85
HH88_3
LCX
75
45.8
29.20
HH88_4
25.97
49.03
HH88_5
6.15
68.85
HH88_6
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Table 6.9
Thermal fluid model testing matrix continued.
HH97
Location
Flow Rate (ml/min)
(Proximal)
GuideLiner®
Total
Blood
LAD
75
45.8
29.20
25.97
49.03
6.15
68.85
LCX
75
45.8
29.20
25.97
49.03
6.15
68.85
HH102
Location
Flow Rate (ml/min)
(Proximal)
GuideLiner®
Total
Blood
LAD
75
45.8
29.20
25.97
49.03
6.15
68.85
LCX
75
45.8
29.20
25.97
49.03
6.15
68.85
HH178
Location
Flow Rate (ml/min)
(Proximal)
GuideLiner®
Total
Blood
LAD
75
45.8
29.20
25.97
49.03
6.15
68.85
LCX
75
45.8
29.20
25.97
49.03
6.15
68.85
HH259
Location
Flow Rate (ml/min)
(Proximal)
GuideLiner®
Total
Blood
LAD
75
45.8
29.20
25.97
49.03
6.15
68.85
LCX
75
45.8
29.20
25.97
49.03
6.15
68.85

Model #
HH97_1
HH97_2
HH97_3
HH97_4
HH97_5
HH97_6
Model #
HH102_1
HH102_2
HH102_3
HH102_4
HH102_5
HH102_6
Model #
HH178_1
HH178_2
HH178_3
HH178_4
HH178_5
HH178_6
Model #
HH259_1
HH259_2
HH259_3
HH259_4
HH259_5
HH259_6

Each of the heart models in the thermal-fluid model testing matrix (Table 6.9)
were executed in STAR-CCM+ using the methods described in this chapter. The results
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of each CFD simulation were used to predict the impact of each patient-specific heart
structure on cooling effectiveness. A rationalization for how cooling effectiveness was
defined, as well as a parametric study descibing the impact of patient-specific heart
structure is descibed in detail in Chapter 7.
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Chapter 7
Thermal Fluid Model Predictions
Overview
Studies involving the biophysics of heart cooling remain largely unexplored,
specifically, the biophysics of coronary artery cooling following myocardial infarction.
Experimental studies have explored myocardial protection techniques using computer
simulations to examine topical cardiac cooling [101], and conjugate heat transfer by
pumping cold liquid through the major cardiac chambers [102].
Computational vascular research has focused primarily on computing and
visualizing hemodynamics (i.e. coronary blood shear, pressure, and velocity)
[4][103][104][105], coronary artery fractional flow reserve (FFR) [106], and lumped
parameter modeling [75][107]. A lumped parameter model is a mathematical model that
describes the physiological constraints of a system using parameters that are less
complex, hence lumped [108]. To our understanding, there is no published literature
analyzing the biophysics of localized cooling in patient-specific coronary arteries.
In this study, patient specific left anterior descending (LAD) and left circumflex
(LCX) artery models are used to explore the impact of vascular geometry on thermal
fluid behavior in the coronary arteries [13]. A new thermal model is introduced that could
provide a better understanding of the biophysics of acute myocardial infarction (AMI)
during TH, as well as provide insight to guide more efficient TH device designs and
operation parameters [92].
The objective of this study is to create thermal fluid models of six patient-specific
left main coronary arteries (LMCAs). The goal is to predict arterial blood temperatures
for a variety of hearts and catheter infusion flow rates in the proximal LAD and LCX
vasculature. The following computational fluid dynamics (CFD) models can help
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determine and qualitatively analyze temperature distributions in the LMCA’s and can
help shed light on TH device design and operation to optimize patient outcomes
following AMI.
Parametric Study – Sensitivity Analysis
Our parametric study will explore three questions:
1) What is the impact of heart structure on cooling effectiveness?
2) What is the impact of TH device location placement on cooling effectiveness?
3) Is there a surface area to volume (SA:V) ratio that reveals cooling
effectiveness?
Before these questions can be answered, a basic knowledge of heat transport in
physiological systems is required.
Heat transport in physiological systems is a very complicated phenomenon [109].
The heart circulates blood flow through vascular systems that reduce in size with each
branching network until the blood reaches the capillaries. From the capillaries, small
intravenous vessels are filled with blood which eventually flows into larger vessels that
bring blood back into the hearts circulation system [109]. Figure 7.1 shows the general
impact of blood flow in successively smaller vessels in tissue [149].
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Figure 7.1. The blood temperature as it navigates through blood vessels of varying
diameters, as proposed by Chen and Homes [149]. The dashed line indicates the range of
the tissue temperature surrounding the vessels. Most temperature changes occur in
smaller vessels, whereas large vessels retain blood flow path temperatures for longer
distances.

As seen in Fig. 7.1, most of the temperature change occurs in the smaller vessels,
which contributes to the fact that blood flow temperatures drastically differ from
surrounding tissue when moderately large vessels experience blood flow. Thus, thermal
equilibrium between blood vessels and the surrounding tissue is greater in vessels with
smaller diameters. However, since the scope of this work is limited to the impact of
cooling in the blood flow paths of coronary artery networks, optimizing the depth of
cooled blood flow path temperatures in patient-specific models will be the focus of this
work.
ABT defined. To accurately measure blood flow in blood vessels and artery
networks, an average bulk mass flow rate can be calculated to determine the mean flow
rate at any particular cross-section in the vessel of interest. Therefore, to accurately
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measure a vessel’s mean temperature distribution at any given cross-section, the average
bulk temperature (ABT) can be determined.
The ABT of a fluids cross-section is calculated in STAR-CCM+ using the
following equation (Eq. 2.9) from Chapter 2 [115]:
𝑟𝑜
2 ∫0 𝑢𝑇(𝑟, 𝑥)𝑟𝑑𝑟
𝑟
𝑚 𝑜

𝑇𝐴𝐵𝑇 = 𝑢

2

(2.9)

where 𝑇𝐴𝐵𝑇 is the average bulk temperature of the fluid, 𝑢𝑚 is the mean velocity, and 𝑟𝑜 is
the radius of the cross section of interest.
ABT in patient-specific vascular structures. To determine the ABT for each
patient-specific heart model, cross-sectional planes were created in STAR-CCM+ that
started at the artery inlet and extended down each LAD and LCX mother vessel in 5mm
increments until the planes reached the outlet. The significance of the mother vessel is that
it comprises of the main fluid domain that carries blood from the LMCA ostia to each of
the distal LAD and LCX coronary artery trees. A visual representation of the crosssectional planes created in the LAD (Fig. 7.2) and LCX (Fig. 7.3) arteries shows the mother
vessel used in all human heart (HH) models.
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Proximal Inlet
Mother Vessel Flow Path
C-SP’s

LAD Outlet

Figure 7.2. Cross-sectional planes (C-SP’s) spaced 5mm apart extending from HH259
LAD inlet to the outlet. The mother vessel for each LAD human heart (HH) model
originated at the proximal inlet and extended to each distal LAD outlet.

Proximal Inlet
Mother Vessel Flow Path

C-SP’s

Posterolateral
Branch Outlet

Figure 7.3. Cross-sectional planes (C-SP’s) spaced 5mm apart extending from HH259
LCX inlet to the outlet. The mother vessel for each LCX human heart (HH) model
originated at the proximal inlet and extended to each distal posterolateral branch outlet.
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To determine the impact of coronary vascular structure on cooling effectiveness (CE),
a basic ratio was created with the intent of being simple and analogous to fractional flow
reserve (FFR). FFR is a simple calculation used during intracoronary procedures to
determine the pressure difference across an occlusion [105]. Similar to FFR, CE was
determined as the ratio of the length of the therapeutic hypothermia average bulk
temperature (TH-ABT) in the mother vessel over the entire length of the mother vessel
(Eq. 7.1).

𝐶𝑜𝑜𝑙𝑖𝑛𝑔 𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠 (𝐶𝐸) =

𝐷𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑓𝑟𝑜𝑚 𝐼𝑛𝑙𝑒𝑡 𝑤ℎ𝑒𝑟𝑒 𝐴𝐵𝑇<35°𝐶 (𝑚𝑚)
𝑇𝑜𝑡𝑎𝑙 𝐿𝑒𝑛𝑔𝑡ℎ 𝑜𝑓 𝑀𝑜𝑡ℎ𝑒𝑟 𝑉𝑒𝑠𝑠𝑒𝑙 (𝑚𝑚)

(7.1)

We chose ABTs < 35°C for our studies based on Dae et al. 2018, which conducted
a study analyzing six randomized endovascular cooling trails involving 629 patients [78].
As a result, temperatures < 35°C reduced infarct size from 6.5% in control studies to 30%.
Therefore, ABTs < 35°C were defined as the cut-off temperature for CE. A visual
representation of how CE was applied to each mother vessel flow path is described in
Figure 7.4.
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Figure 7.4. Cooling effectiveness (CE) represents the ratio of the distance from the
proximal inlet where TH-ABTs are evident in the mother vessel over the entire length of
the mother vessel. If TH-ABTs are evident up to and including half the length of the vessel,
then this vessel would have 50% CE. Furthermore, if TH-ABTs were measured at the
outlet, then the vessel would have 100% CE.

The cooling effectiveness calculation (Eq. 7.1) was used as a post-processing
method and was applied to all CFD simulations comprising of six HH models and 29.20,
49.03, 68.85 mL/min GuideLiner® flow rates.
ABT in single heart with single flow rate. After the cross-sectional planes were
created in the LAD and LCX arteries for each patient-specific HH model, the thermal fluid
simulations were executed in STAR-CCM+ using a single flow rate obtained from the in
vitro mock loop study for each HH patient model. The ABT for each cross-sectional plane
along the artery’s fluid flow path were plotted for the LAD (Fig. 7.5) and LCX (Fig. 7.6)
from HH178.
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Figure 7.5. ABT along the LAD mother vessel flow path with single GuideLiner® flow
rate at 29.2 mL/min for HH178.
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Distance From HH178 LCX Inlet
Figure 7.6. ABT along the LCX mother vessel flow path with single GuideLiner® flow
rate at 29.2 mL/min for HH178.
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As seen in the above figures, a proximal GuideLiner® flow rate of 29.2 mL/min in
each LAD and LCX for patient HH178 resulted in dissimilar ABTs trends extending along
the mother vessel. The LAD resulted in an ABT of 34.86°C reaching 45mm into the artery,
while the LCX resulted in 34.92°C ABT reaching 40mm in the artery. This indicates that
the anterior descending and left circumflex artery mother vessel flow paths within patients
have variability in cooling potential outcomes.
ABT in all hearts with single flow rate. Cross-sectional planes were created along
the flow path in 5mm increments for each of the six representative heart (RH) models. All
LAD (Fig. 7.7) and LCX (Fig. 7.8) RH models were executed in STAR-CCM+ using a
29.4℃ infusate fluid mixture (as described in Chapter 6) at a flow rate of 29.2 ml/min,
which is similar to a 30 ml/min flow rate used in transcatheter studies to deliver saline in
the proximal left main coronary arteries (LMCA) [99].
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Figure 7.7. All LAD representative heart models using a 29.4℃ infusate fluid mixture at a
flowrate of 29.2 ml/min. Temperature drop in HH88 and HH97, at locations of about 3040 mm, are discussed in detail in the next section.
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Figure 7.8. All LCX representative heart models using a 29.4℃ infusate fluid mixture at a
flowrate of 29.2 ml/min.
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Since each representative heart (RH) model was infused with an identical
GuideLiner® flow rate (29.2 mL/min) and temperature (29.4℃) 3-5mm into the proximal
artery, the results were localized to the 10mm plane (Figs. 7.7 and 7.8) for consistency.
Figure 7.7 describes the impact of biovariability in the LAD using a single GuideLiner®
flow rate, which resulted in HH88 experiencing good cooling potential where ABTs <35℃
reached 100mm into the mother vessel, as compared to HH259 where ABTs <35℃ reached
only 40mm into the mother vessel. Similarly, HH88 in the LCX experienced the greatest
cooling potential while HH55 experienced the poorest, reaching warmer temperatures
quicker.
ABT in single heart with multiple flow rates. The thermal fluid simulation for patient
HH259 was executed using the three catheter flow rates obtained from the in vitro mock
loop study; 29.2 ml/min, 49.03 ml/min, and 68.85 ml/min. The ABT for each crosssectional plane along the artery’s fluid flow path was plotted for each LAD (Fig. 7.9) and
LCX (Fig. 7.10) artery.
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Figure 7.9. Results of ABT at each cross-sectional plane location for HH259 LAD using
flow rates obtained from in vitro mock loop study; 29.2 ml/min, 49.03 ml/min, and 68.85
ml/min. The rapid spike in ABT at the 40mm plane is the result of a bifurcated septal
perforator branch that deviated from the mother vessel.
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Figure 7.10. Results of ABT vs cross-sectional plane location for HH259 LCX using flow
rates obtained from in vitro mock loop study; 29.2 ml/min, 49.03 ml/min, and 68.85
ml/min. The rapid spike in ABT at the 70mm plane resulted in a bifurcation from the
second obtuse marginal branch that deviated from the mother vessel.

As predicted by Chen and Homes [149], most of the temperature change occurred
in smaller vessels downstream between 3000µm and 1000µm, which suggests that thermal
equilibrium between the vessel walls and the temperature of the fluid is significantly
greater in vessels with smaller diameters. Our results indicate that abrupt ABT drops at or
around 1000µm diameters generally occur between 40-55mm from the catheter inlet,
which falls within the arterial diameters of Chen and Homes findings [142]. Additionally,
the ABT in the LAD reached 36.55℃ at 135mm from the artery inlet (Fig. 7.9) using 68.85
ml/min infusate flow. For the LCX, the ABT resulted in 36.12℃ at 135mm from the inlet
(Fig. 7.10) using 68.85 ml/min infusate flow.
Although both ABTs from Figure 7.9 and 7.10 were recorded at 135mm
downstream from the artery inlet, the cross-sectional area for the LAD plane (Fig. 7.11)
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was smaller than the cross-sectional area of the LCX plane (Fig. 7.12), which justifies the
increased ABT in the LAD plane.

Figure 7.11. Cross-sectional area of the 135mm cross-sectional plane from HH259 LAD.
Note: Cross-sectional area: 1.935e-2 mm2. Average bulk temperature (ABT): 36.55℃ at
68.85 ml/min infusate flow.

Figure 7.12. Cross-sectional area of the 135mm cross-sectional plane from HH259 LCX.
Note: Cross-sectional area: 1.968e-2 mm2. Average bulk temperature (ABT): 36.12℃ at
68.85 ml/min infusate flow.
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Cooler temperatures set the foundation for greater cooling rates. The colder the
GuideLiner® flow is, the more quickly TH-ABTs can reach into the distal arteries. As
evident in Figures 7.9 and 7.10, GuideLiner® flow rates of 68.85 mL/min most quickly
cooled and reached the greatest cooling potential along the length of the artery.
Furthermore, these models do not predict tissue cooling rates, but rather, ABT distributions
of the coronary artery fluid flow path in each patient-specific HH model.
ABT in all hearts with multiple flow rates. The concluding ABT study involved
analyzing the impact of biovariability on cooling effectiveness across all six patientspecific heart models using all three GuideLiner® flow rates.
In the event of an AMI, clinicians considering localized cooling treatment methods
should consider the impact of biovariability from patient to patient and the probable
outcomes that could result using variable GuideLiner® flow rates. To help describe this
phenomenon, we analyzed the ABTs along each HH model’s mother vessel flow path for
all hearts using all GuideLiner® flow rates. Final results for the LAD and LCX mother
vessel flow paths are prominent in Figure 7.13 and Figure 7.14, respectively.
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Figure 7.13. The impact of all six HH models on CE with their corresponding GuideLiner® flow rates in each LAD
mother vessel.
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Figure 7.14. The impact of all six HH models on CE with their corresponding GuideLiner® flow rates in each LCX
mother vessel.

The summary of findings herein describe the impact of biovariability between
patient-specific LMCA vascular structures on proximal GuideLiner® flow rates. Higher
GuideLiner® flow rates resulted in deeper ABT cooling potential in both the LAD and
LCX arteries. Although CE varied between patients, GuideLiner® flow rate was the
dominant factor for reaching TH-ABTs in the distal coronary arteries. Further analysis of
these findings are described in greater detail later in this chapter.
ABT dip in HH88 and HH97. A temperature drop was evident in heart HH88 and
was suspected to be an artifact issue in the STAR-CCM+ physics solvers. The drop
occurred between the 30 and 35mm planes and dropped in ABT from 34.47℃ to 32.7℃.
This physical phenomenon could suggest that there was a mysterious thermal energy sink,
where thermal energy was removed in the blood stream downstream to produce lower
temperatures in the artery network, which is not physically accurate. According to the first
law of thermodynamics, energy can neither be created nor destroyed in an isolated system
[150]. Therefore, further investigation was made to analyze our method for obtaining ABT.
Both LAD ABT distributions for patient HH88 (Fig. 7.15) and HH97 (Fig. 7.16) consisted
of having noticeable artifact issues and were further analyzed.
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Figure 7.15. ABT distribution along mother vessel of patient HH88 LAD with artifact issue
occurring between planes 30mm and 35mm, at 29.2 ml/min. The ABT steadily increases
until the thermal fluid flow path exits the LAD outlet.

38
37

ABT (℃)

36
35
34
33
32
31
30

5mm Catheter Inlet
10mm
15mm
20mm
25mm
30mm
35mm
40mm
45mm
50mm
55mm
60mm
65mm
70mm
75mm
80mm
85mm
90mm
95mm
100mm
105mm
110mm
115mm
120mm
125mm
130mm
135mm
140mm
145mm
150mm
155mm
160mm
Outlet LAD

29

Distance From HH97 LAD Inlet
Figure 7.16. ABT distribution along flow path of patient HH97 LAD with numerous
artifact issues originating at the 20mm plane. GuideLiner® infusate flow rate: 29.2 ml/min.
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After much consideration, it was determined that the assumed artifact in Figures
7.15 and 7.16 were not associated with the inherent approximations of the finite volume
method, but rather, an issue concerning the stratification of flow. To dive deep in to this
issue of stratification, rather than creating cross-sectional planes only along the mother
vessel, we created a continuation of planes in 5mm increments along each bifurcated
branch (Fig. 7.17) that had deviated from the mother vessel.

Blood Inlet
GuideLiner Inlet

Cross-Sectional Planes
in 5mm Increments

35mm
Plane
35mm Planes

Figure 7.17. Continuation of planes in 5mm increments along each bifurcated branch that
had deviated from the mother vessel in HH88 LAD.

ABT cross-sectional planes extended from the proximal LAD inlet and spread into
each bifurcated artery in 5mm increments. Each individual ABT plane that extended down
the artery network was grouped with the ABT plane that extended an equal distance from
the proximal inlet. For example, all three 35mm planes (Fig. 7.17) were summed together
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to determine a final ABT that resembled a stratified fluid mixture 35mm from the artery
inlet. The summation of planes was determined using the following equation:
𝐴𝐵𝑇 𝑆𝑢𝑚𝑚𝑎𝑡𝑖𝑜𝑛 = (𝑚̇

1
1 +𝑚̇2 +⋯

) ((𝑚̇1 𝐴𝐵𝑇1 ) + (𝑚̇2 𝐴𝐵𝑇2 ) + ⋯ )

(7.1)

where 𝑚̇1 and 𝑚̇2 are the flowrates of branches 1 and 2, respectively, and 𝐴𝐵𝑇1 and 𝐴𝐵𝑇2
are the average bulk temperatures of branches 1 and 2, respectively.
An image of the temperature distribution for the 35mm planes from HH88 LAD (Fig.
7.18) helps to visualize the stratification of flow.

a.

b.
35mm ABT Planes

35mm C

35mm B
A

C

B

35mm A

Figure 7.18. HH88 LAD bifurcations of 35mm branches A, B, and C (a). The majority of
chilled infusate flowed into branch A and only a minute amount passed into branches B
and C. The cross-sectional 35mm ABT planes (b) are summed together in STAR-CCM+
using a form of Eq. 7.1 to produce combined ABT values.

The ABT’s for branches A, B, and C from HH88 LAD were plotted (Fig. 7.19) to
visualize the flow in each bifurcation between the 10mm and 65mm planes (see
Appendix D for a qualitative analysis of how ABT contours change along the fluid flow
path in a simple 3D tube).
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Figure 7.19. HH88 LAD with 29.2 ml/min proximal infusate flow comparing the ABT
planes for branches A, B, and C.

STAR-CCM+ post-processing allowed us to calculate the ABT summations (Eq.
7.1) for each location along the artery pathway by creating an average bulk temperature
report. The results of each stratified ABT were plotted as a function of distance along the
artery (Fig. 7.20), which resulted in a plot with no identifiable artifact or stratification of
flow.
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Combined

Figure 7.20. GuideLiner® flow rate (29.2 mL/min) in HH88 LAD with no impact of flow
stratification using ABT summation from branches A, B, and C. The ABT’s for each
corresponding distance were summed together to determine a final ABT at each distance
extending down the artery network.
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The flow stratification from HH97 was resolved using the same method from
HH88. Cross-sectional planes were created in 5mm increments that extended down the
mother vessel (Fig. 7.21) of each bifurcation.

Blood Inlet
GuideLiner® Inlet

15mm Planes

20mm Planes

35mm Planes
Figure 7.21. Continuation of planes in 5mm increments along each bifurcated branch that
had deviated from the mother vessel in HH97 LAD.

The CFD simulation was executed for Fig. 7.16 and the ABT’s from the
GuideLiner® inlet to the cross-sectional plane at 35mm were plotted comparing the ABT
for the vessel pathway of interest verse the combined ABT for each bifurcated pathway
(Fig. 7.22).
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Figure 7.22. HH97 ABT’s comparing the vessel pathway of interest vs the combined ABT
for all branches between the GuideLiner® inlet and the 35mm plane.

Having closely examined the impact of vascular geometry on cooling, at a single
flow rate, the next logical exploration involved alternative cooling catheter operating
conditions. The 7F guiding catheter and 7F GuideLiner® used in the in vitro mock loop
system (see chapter 4) was implemented for the purpose of determining how the guide
catheter and GuideLiner® performed in physiological conditions. Guide catheters are
manufactured in many different lengths and diameters and have many different functions
in cardiovascular procedures [151]. They can be used as conduits for wire transport,
contrast injections, and advancing interventional devices. Guide catheters are also known
for their high kink resistance, device compatibility, and radiopacity features [151]. A
standard Cordis® 7F guide catheter and GuideLiner® was selected for this study and
tested in the in vitro mock loop to determine outlet temperatures and corresponding
flowrates to be used in computational fluid dynamics (CFD) simulations. A visual
representation for each patient-specific LAD (Fig. 7.23) and LCX (Fig. 7.24) network
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was generated to observe the impact of the standard catheter’s performance on cooling
effectiveness.

HH55 LAD

HH88 LAD

HH102 LAD

HH178 LAD

HH97 LAD

HH259 LAD

Figure 7.23. Temperature distributions executed in STAR-CCM+ for all patient-specific
LAD models using a GuideLiner® flow rate of 29.2 ml/min at 29.4℃ in all models.
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HH102 LCX

HH178 LCX

HH259 LCX

Figure 7.24. Temperature distributions executed in STAR-CCM+ for all patient-specific
LCX heart models using a GuideLiner® flow rate of 29.2 ml/min at 29.4℃ in all models.

Impact of TH device location placement on cooling effectiveness. Localized
TH transcatheter procedures in patient-specific heart vasculature can have varying results
on cooling effectiveness (Figs 7.23 and 7.24). In this section, we analyzed the impact of
GuideLiner® cooling effectiveness in each patient-specific LAD and LCX vasculature.
The tip of the GuideLiner® was positioned in the proximal LAD and LCX for each
human heart, and the ABT distributions for HH55 (Fig. 7.25) and HH178 (Fig. 7.26)
were compared using flowrates at 29.2 ml/min and 68.85 ml/min for each patient.
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Figure 7.25. Impact of proximal GuideLiner® placement in the LAD and LCX for HH55
using 29.2 ml/min and 68.85 ml/min flowrates. ABT’s below black-dotted line represent
effective therapeutic hypothermia cooling (<35℃).
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Figure 7.26. Impact of proximal GuideLiner® placement in the LAD and LCX for
HH178 using 29.2 ml/min and 68.85 ml/min flowrates. ABT’s below black-dotted line
represent effective therapeutic hypothermia cooling (<35℃).
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Although identical GuideLiner® flowrates and inlet temperatures were delivered
to the proximal end of each LAD and LCX HH model, the assumption that each artery
network will experience identical cooling effectiveness was not found. Effective TH
temperatures were evident in all LAD and LCX networks, however, the distance by
which TH was effective varied between patients (Table 7.1).

Table 7.1
Summary of TH cooling effectiveness for all HH patients using 29.2 ml/min and 68.85
ml/min GuideLiner® flowrates.
Effective TH-ABT
Effective TH-ABT
at 29.2 ml/min
at 68.85 ml/min
Human Heart
LAD
LCX
LAD
LCX
50mm
35mm
90mm
90mm
HH55
95mm
60mm
> 130mm
95mm
HH88
55mm
55mm
100mm
> 90mm
HH97
35mm
50mm
> 80mm
> 90mm
HH102
45mm
50mm
100mm
95mm
HH178
35mm
35mm
90mm
105mm
HH259
Note. Therapeutic hypothermia average bulk temperature (TH-ABT) represents the
distance from the inlet up to and including the plane listed where TH temperature
conditions exist (<35℃) [152]. The greater-than sign obverse to the distance planes
signifies that the planes reached the artery outlet, and that effective TH-ABT’s continued
past the outlet.

Based on compact heat exchanger design, surface area to fluid volume ratio is a
logical parameter to examine for intravascular cooling. Surface area to volume (SA:V)
ratios were calculated in Chapter 5 (Fig. 5.6) for all LAD and LCX RH models. The goal
of calculating SA:V ratios was to correlate their impact on heart cooling effectiveness
levels. The SA:V ratios were grouped in ascending order and plotted vs effective THABT distance for each corresponding flow rate in the LAD (Fig. 7.27) and LCX (Fig.
7.28) arteries.
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Figure 7.27. Impact of surface area to volume (SA:V) ratios on cooling effectiveness in
the LAD pathway of interest for each representative heart (RH) model. Cooling
effectiveness is the ratio of the length of TH-ABT in the mother vessel over the entire
length of the mother vessel. Therapeutic hypothermia average bulk temperature (THABT) represents the distance from the inlet up to and including the plane listed where TH
temperature conditions exist (<35℃). In general, smaller SA:V ratios lead to deeper
cooling, as would be expected. Note: SA:V ratio values are listed from left to right in
ascending order.
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LCX Flowrates vs Effective TH-ABT (<35℃)
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Figure 7.28. Impact of surface area to volume (SA:V) ratios on cooling effectiveness in
the LCX pathway of interest for each representative heart (RH) model. Cooling
effectiveness is the ratio of the length of TH-ABT in the mother vessel over the entire
length of the mother vessel. Therapeutic hypothermia average bulk temperature (THABT) represents the distance from the inlet up to and including the plane listed where TH
temperature conditions exist (<35℃). In general, smaller SA:V ratios lead to deeper
cooling, as would be expected. Note: SA:V ratio values are listed from left to right in
ascending order.

Figures 7.27 and 7.28 reveal the impact of SA:V ratios, listed from left to right in
ascending order, on cooling effectiveness in the fluid pathway of interest for all LAD and
LCX artery models. Three GuideLiner® flowrates at 29.2 ml/min, 49.03 ml/min, and
68.85 ml/min were infused eccentrically at each proximal inlet and compared to the max
distance in the pathway of interest where ABT’s contained TH (<35℃) temperatures.
LAD artery simulations for RHs HH55, HH88, HH97, and HH102 revealed a
direct correlation between effective TH cooling and low SA:V ratio values for all three
flowrates. However, LCX artery results for RHs HH88, HH97, HH178, and HH259
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revealed a direct correlation between effective TH cooling and low SA:V ratio values at
49.03 ml/min and 68.85 ml/min flowrates.
As mentioned in Chapter 5, SA:V ratios are small in artery networks with
enlarged internal volumes [142]. This implies that TH cooling will be conserved
downstream since blood flow temperatures drastically differ from surrounding tissue
when moderately large vessels experience blood flow [149]. Small SA:V ratios reveal
that for every unit of volume, there is less surface area to exchange heat. If a vascular
network maintains larger diameters directly near or near distal to the guide extrusion tip,
the cooling effect will travel deeper in the vessel. Therefore, small SA:V ratios imply
larger vessels.
A sensitivity analysis for proximal LAD and LCX lengths with respect to cooling
effectiveness was determined for the 68.85 mL/min GuideLiner® flow rates. Figures 7.29
and 7.30 illustrate the sensitivity of proximal length to the total mother vessel length for
each LAD and LCX artery simulation.
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Figure 7.29. Sensitivity of proximal length to mother vessel length for each HH LAD
model. Proximal length revealed significant sensitivity to cooling effectiveness in HH88
and HH102, as the two longest proximal length revealed the greatest cooling
effectiveness. However, no significant sensitivity was determined between the remaining
HH models.
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Figure 7.30. Sensitivity of proximal length to mother vessel length for each HH LCX
model. Proximal length revealed no significant sensitivity to cooling effectiveness since
the longest (HH178) and shortest (HH55) proximal artery lengths played very little
impact on cooling effectiveness, as compared to HH97 and HH102.
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Cooling effectiveness in each mother vessel was illustrated for the LAD (Fig.
7.29) and LCX (Fig. 7.30). Proximal artery lengths ranged between 12mm to 31.7mm in
the LAD and 9.23mm to 57.5mm in the LCX. The sensitivity of the proximal artery
lengths to the total mother vessel lengths provided no significant correlation to cooling
effectiveness for all HH models.
To increase the rigor of our analyses, the entire vascular networks were
characterized to determine the impact of cooling effectiveness down each first and second
obtuse marginal branch and posterolateral branch in the LCX, and down each first and
second diagonal branch, septal branch, and anterior descending branch in the LAD. Total
cooling in the vascular network was determined using cooling effectiveness from each
daughter vessel as described by the following equation:
𝜂𝑇𝐶 =

𝐿𝑒
∑𝑛
𝑖=1⋅
𝐿

𝑁

(7.1)

where 𝜂𝑇𝐶 is total cooling in the vascular network (𝜂𝑇𝐶 = 1 represents 100% CE), 𝐿𝑒 is
the effective length in each branch of interest where TH-ABTs < 35°C, L is the total
length of each branch of interest, and 𝑁 represents the sum of the total number of
branches in the network of interest.
A visual representation of Eq. 7.1 applied to the LCX artery of patient’s HH88,
HH97, and HH259 is illustrated in Figure 7.31.
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Figure 7.31. Characterization of vascular networks for HH88, HH97, and HH259 LCX
represented using 68.85 mL/min GuideLiner® flow rates. First obtuse marginal (1om),
second obtuse marginal (2ob), and posterolateral (Plb) branches were characterized using
Eq. 7.1. Total cooling 𝜂𝑇𝐶 in HH97 resulted in 97.63% CE in the artery network, while
HH88 and HH259 resulted in 85.26% and 76.02% total CE in each vascular network,
respectively.

We acknowledge this method is subjective, and intend that it be used as a simple
aid to help and support patient care. The purpose of the proposed method is to help
stimulate a deeper understanding of intracoronary cooling and provide a deeper
understanding of TH treatment methods to improve patient outcomes following AMI.
The HH97 LCX artery network resulted in having 97.63% CE in its total vascular
network, and would be recommended as a good candidate for localized cooling therapy.
On the other hand, we would be reluctant to recommend HH88 and HH259 LCX arteries
as candidates for this treatment due to their moderate total network cooling potential of
85.26% and 76.02%, respectively.
The total network cooling effectiveness for patients HH55 and HH178 was not
included in the following analyses due to poor mother vessel and total network cooling
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performance. The remaining patient models provided good cooling performances and
were analyzed using a dimensionless parameter of SA:V multiplied by total network
length. These values were plotted against 𝜂𝑇𝐶 and mother vessel cooling effectiveness for
each LAD and LCX network using the 68.85 mL/min GuideLiner® inlet flow rate (Fig.
7.32).
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Figure 7.32. Analyses of total network cooling effectiveness (𝜂𝑇𝐶) for each HH model
compared to SA:V ⋅ total network length. Triangle markers represent mother vessel
cooling effectiveness (𝐿𝑒/𝐿) for each HH model at 68.85 mL/min GuideLiner® flow rate,
while circles represent SA:V ⋅ total network length for each HH model. A significant
reduction in total network cooling effectiveness is evident when SA:V ⋅ total network
length ratios exceed 700. Note: red dotted line represents 700 cut-off value between good
and bad heart cooling candidates.

Total network cooling effectiveness is significantly reduced when SA:V ⋅ total
network length ratios exceed 700. The point where these values exceed 700 is where 𝜂𝑇𝐶
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is reduced from 97.63% to 85.26%. This is also indicative of the fact that mother vessel
cooling effectiveness also followed suit by decreasing from 100% to 74.8%. The
comparison between these two trends suggest that a cutoff of 700 SA:V ⋅ total network
length ratio could be approximated as a reasonable localized cooling candidate parameter.
However, this assumption is limited by the number of patient-specific vascular models
employed in this study. A more robust analysis is needed to increase the fidelity of this
assumption by improving upon the modeling physics of the CFD simulations and
broadening the patient-specific model population.
In lieu of the importance of these findings and insights attained from this study, a
comparison of HH specifications and published works must also be made to preserve the
fidelity of this work.
Comparison with Published Works
Patient-specific heart specifications, medical history, and intracoronary
temperature predictions were compared with published works that performed similar
localized cooling studies in the coronary arteries (Table 7.2) [13][96].
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Table 7.2
Comparison of patient specifications and medical history with patients in similar heart
cooling studies.
Comparison of Work
Present Work Otterspoor [13]
McGarvey [96]
<35℃ at each
5℃ below body
3.4℃ below body
Intracoronary Temperature
artery outlet
temp. proximal
temp. proximal to
Goal
to occlusion
occlusion
Patient population
N=6
N = 10
N = 10
LAD (N = 6)
LAD (N = 6)
LAD (N = 3)
LCX (N = 6)
LCX (N = 1)
Mid-LAD (N = 2)
Cooling Location
RCA (N = 3)
LCX (N = 1)
RCA (N = 4)
Male
N=3
N=7
N=9
Sex
N=2
N=3
N=1
Female
(1 unknown)
41 ± 27
61 ± 11
55 ± 8
Age
(1 unknown)
Medical History
Diabetes Mellitus
N=1
N=3
N=2
Smoking
N=1
N=5
N=6
Cardiac Medical History
Cardiac Arrest
N=1
----Hypertension
N=2
N=5
N=2
Sinus Bradycardia
N=2
----Note. Left anterior descending artery (LAD), left circumflex (LCX), and right coronary
artery (RCA).

Hypothermia trials have found that patients who undergo therapeutic hypothermia
treatments with temperatures <35℃ prior to reperfusion result in reduced infarct sizes
[152]. Figures 7.33 to 7.39 illustrate the structural-thermal relationship of preferred
cooling candidates with respect to flow rate.
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LAD Outlet

Figure 7.33. Structural-thermal relationship in HH88 LAD for 49.03 ml/min guide
extension flow rate. Note proximal guide extension inlet temperature is 23.16℃, and
LAD outlet temperature is 34.13℃.
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LAD Outlet

Figure 7.34. Structural-thermal relationship in HH88 LAD for 68.85 ml/min guide
extension flow rate. Note: proximal guide extension inlet temperature is 19.2℃, and LAD
outlet temperature is 32.69℃.
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LCX Outlet

Figure 7.35. Structural-thermal relationship in HH97 LCX for 68.85 ml/min guide
extension flow rate. Note: proximal guide extension inlet temperature is 19.2℃, and LCX
outlet temperature is 34.55℃.
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LAD Outlet

Figure 7.36. Structural-thermal relationship in HH102 LAD for 49.03 ml/min guide
extension flow rate. Note proximal guide extension inlet temperature is 23.16℃, and
LAD outlet temperature is 33.1℃.
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LAD Outlet

Figure 7.37. Structural-thermal relationship in HH102 LAD for 68.85 ml/min guide
extension flow rate. Note: proximal guide extension inlet temperature is 19.2℃, and LAD
outlet temperature is 30.47℃.
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LCX Outlet

Figure 7.38. Structural-thermal relationship in HH102 LCX for 49.03 ml/min guide
extension flow rate. Note: proximal guide extension inlet temperature is 23.16℃, and
LCX outlet temperature is 34.34℃.
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LCX Outlet

Figure 7.39. Structural-thermal relationship in HH102 LCX for 68.85 ml/min guide
extension flow rate. Note: proximal guide extension inlet temperature is 19.2℃, and LCX
outlet temperature is 31.54℃.

Intracoronary TH cooling techniques employed in our study resulted in
predictions that were similar to the results of the following published works.
In a study performed by Otterspoor et al., chilled saline was delivered proximal to
occluded arteries in the LAD using 10-30 mL/min flow rates at 20℃ [13]. The goal of the
study was to reach a target temperature of 33℃ in the distal LAD using a 10 patient
population. Temperature probes monitored the temperature of the saline during each
operation while the occlusion was removed and reperfusion was induced (Fig. 7.40).
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Figure 7.40. Temperature vs time plot for the proximal, mid, and distal infarct
temperature probes during the infusion of chilled saline at 20℃ in the coronary arteries.
Proximal intracoronary temperatures reached 30℃ during the occlusion phase and
increased to ~33℃ for the duration of reperfusion prior to reaching body temperature at
the end of the infusion.

A preceding study also analyzed a ten patient population but targeted their therapy
towards patients with percutaneous coronary interventions (PCI) only, rather than those
suffering from ST elevated myocardial infarction (STEMI). This study involved the use
of TH during PCI with the goal of reducing intracoronary blood temperatures by 3.4℃
(33.6℃) at the occlusion site (Fig. 7.41) [97].
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Figure 7.41. Temperature vs time display for intracoronary blood temperatures using TH
therapy during PCI. Intracoronary blood temperatures were targeted consistently
maintained around 33℃ for the duration of the procedure. TH temperatures were
maintained proximal to the occlusion in the coronary arteries for about 1 min and 15
seconds.

Each of the ten patients were infused with chilled saline proximal to an occlusion
until their intracoronary blood temperatures reached 33℃. Target temperatures of 33℃
was consistently maintained for the duration of the procedure.
As observed in Fig. 7.40 and Fig. 7.41, intracoronary blood temperatures were
reduced to 33℃ locally in both the LAD and LCX arteries. Although these studies
comprise of small patient populations, each study reported positive outcomes following
the procedure with no signs of patient discomfort from shivering while reaching and
maintaining target TH temperatures in minutes [13][97]. While these therapies observed
the duration to reach and maintain target TH temperatures in the LAD and LCX arteries,
the impact of reducing infarct and the relation between distal artery temperature with
myocardial temperatures have yet to be explored.
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Despite the fact that localized TH targeted temperature management (TTM) is a
relatively new therapy, Abbott Laboratories, a world renown biotechnology company,
has recently initiated a randomized interventional clinical trial in Europe involving 200
patients with an estimated study duration of three years (January 1, 2019 to January 1,
2022) [146]. The goal of this study is to combine selective intracoronary hypothermia
with primary percutaneous coronary interventions (PPCI) to reduce infarct size and
permanent myocardial damage.
Similarly, our aim was to determine the impact of patient-specific coronary artery
vascular structures on localized therapeutic hypothermia cooling. We chose six patientspecific LMCA representative heart (RH) models from the VHL and compared
temperature distributions for a variety of flowrates in the LAD and LCX arteries. The
structural thermal-fluid relationship was compared between each LAD and LCX
simulation to determine cooling effectiveness levels. Based on their cooling
effectiveness, we categorized each RH model as a preferred candidate or non-preferred
candidate for localized heart cooling. The key takeaways and insights revealed from this
work are discussed in Chapter 8.
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Chapter 8
Conclusions and Future Work
Approaches and Recommendations for Cooling Hearts
Patient-specific left anterior descending (LAD) and left circumflex (LCX) artery
structures and their impact on cooling effectiveness have been quantified using the finite
volume method. Surface area to volume ratios, relationships between mother and
daughter branches, and effective depth of therapeutic hypothermia have been explored.
Preferred candidates for localized cooling consisted of heart structures that
resulted in TH-ABT at the outlets. As illustrated in Fig. 7.32 from Chapter 7, a significant
reduction in total network cooling effectiveness is evident when SA:V ⋅ total network
length ratios exceed 700. Any value below this ratio resulted in total network cooling
effectiveness levels greater than 97.63 %, while values above this ratio resulted in total
network cooling effectiveness levels below 85.26%. Therefore, preferred candidates had
structural-thermal relationships linked to low values of SA:V ratios multiplied by total
network length (Chapter 7 – Fig. 7.32).
High GuideLiner® infusate flow rates, specifically greater than and including
49.03 mL/min, were linked to TH-ABTs deep within the LAD and LCX mother vessels.
Average cooling potential depth was slightly higher in the LAD mother vessel compared
to each LCX mother vessel (Fig. 8.1).
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Average Distance to TH-ABTs
(mm)

120

Average TH-ABT Distance for each GuideLiner® Flow Rate
in the LAD and LCX Mother Vessel

100
80
60
40
20
0

GuideLiner® Flow Rate
Figure 8.1. Average cooling potential depth in the LAD and LCX mother vessel. LAD
average cooling potential was deeper in each mother vessel compared to the LCX.
However, standard deviations were smaller in the LCX, especially for higher flow rates.

The standard deviation for each average TH-ABT depth potential was smaller
with higher flow rates, and resulted in smaller deviations in the LCX arteries. Preferred
heart cooling candidates were linked to GuideLiner® flow rates above 49.03 mL/min,
which not only provided deeper cooling potential, but also provided a tighter standard
deviation which improved accuracy for maintaining TH-ABTs.
A linear regression model was used to determine the relationship between input
and output parameters from our CFD results. For this study, we analyzed the relationship
between mother vessel CE (input) and 𝜂𝑇𝐶 (output). These parameters were investigated
for each GuideLiner® flow rate (Fig. 8.2) and a best fit linear regression model was used
to determine how well our model fit the data.
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The linear regression model for each GuideLiner® flow rate resulted in the
highest flow showing the most promise for providing an accurate model. High
GuideLiner® flow rates (68.85 mL/min) resulted in an 𝑅 2 value of 0.9273, which
statistically associated the percent variance between the dependent variable (𝜂𝑇𝐶 for each
HH model) and the independent variable (mother vessel CE). Medium GuideLiner® flow
rates (48.03 mL/min) resulted in having an 𝑅 2 value of 0.8843, while the low flow rate
(29.2 mL/min) resulting in an 𝑅 2 value of 0.589, which is a statistically poor model.
Therefore, the above linear regression models have demonstrated that GuideLiner® flow
rates have a significant impact on 𝜂𝑇𝐶 predictions.
Heart candidates that had fewer bifurcations stemming from the mother branch
and fewer number of outlets in the artery network generally resulted in having better
cooling outcomes, meaning TH-ABTs were able to travel deeper into the mother vessel.
These results are illustrated by a linear fit trendline to the scatter plot data representing
the number of diverting branches from the mother vessel (Fig. 8.3) and the number of
outlets in the artery network (Fig. 8.4) with respect to decreasing values of 𝜂𝑇𝐶 .
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Number of Diverting Branches from
Mother Vessel

Diverting Branches from Mother Vessel vs Decreasing 𝜂𝑇𝐶
14
12
10
8
6
4
2
0
HH102 HH88 HH102 HH97 HH88 HH259 HH178 HH55 HH178 HH97 HH55 HH259
LAD LAD LCX
LCX
LCX
LCX LAD LCX
LCX LAD LAD LAD

Decreasing 𝜂𝑇𝐶
Number of Diverting Branches

Linear (Number of Diverting Branches)

Figure 8.3. The relationship between the number of diverting branches from the mother
vessel and decreasing total network cooling effectiveness (𝜂𝑇𝐶 ) (from left to right). The
linear fit trendline suggests that 𝜂𝑇𝐶 is likely to decrease as the number of diverting
branches from the mother vessel increase.

Number of Outlets in Artery Network

Number of Outlets in Network vs Decreasing 𝜂𝑇𝐶
35
30
25
20
15
10
5
0
HH102 HH88 HH102 HH97 HH88 HH259 HH178 HH55 HH178 HH97 HH55 HH259
LAD LAD LCX
LCX
LCX LCX LAD LCX
LCX LAD LAD LAD

Decreasing 𝜂𝑇𝐶
Number of Outlets in Artery Network

Linear (Number of Outlets in Artery Network)

Figure 8.4. The relationship between the number of outlets in the LAD and LCX artery
network and decreasing total network cooling effectiveness (𝜂𝑇𝐶 ) (from left to right). The
linear fit trendline suggests that 𝜂𝑇𝐶 decreases as the number of outlets increase.
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Heart candidates that had an increasing amount of outlets in the LAD and LCX
artery network tended to have poorer 𝜂𝑇𝐶 . The linear trendline model was used to
determine a relationship between the number of diverging branches from the mother
vessel and the number of outlets in the artery network for each candidate’s 𝜂𝑇𝐶 . We
recommend that the linear model only be considered as an optional parameter for
determining optimal TH outcomes for each patient. Since a larger patient-specific
population in needed to confirm the fidelity of this assumption, all LAD and LCX artery
networks expressing these “features” are not necessarily indicative of preferred
candidates for heart cooling.
To determine which methods promote effective cooling in the LAD and LCX
arteries, the TH-ABT depth potential was analyzed. This method involved analyzing the
ratio of TH-ABT depth with respect to the length of the mother vessel and comparing
those values to their corresponding flow rates in ascending order of SA:V ratios. A
narrative of good and bad candidates for localized cooling in the LAD (Fig. 8.5) and
LCX (Fig. 8.6) arteries is described with respect to effective TH-ABT levels.
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100.00
90.00

Mother Vessel CE (%)

80.00
70.00
60.00
50.00
40.00
30.00
20.00
10.00
0.00
29.2 ml/min
HH88

49.03 ml/min
HH97

HH55

HH102

68.85 ml/min
HH178

HH259

GuideLiner® Flow Rate
Figure 8.5. Percent of LAD pathway (mother vessel) experiencing TH-ABT. Increasing
SA:V ratios are from left to right for each flow rate. HH88 and HH102 resulted in 100%
effective rates at 49.03 and 68.85 ml/min flow rates. Effective rates of 100% result in
TH-ABT’s (<35℃) evident at the LAD outlets.
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GuideLiner® Flow Rate
Figure 8.6. Percent of LCX pathway experiencing TH-ABT. Increasing SA:V ratios are
from left to right for each flow rate. HH102 and HH97 resulted in 100% effective rates at
49.03 and 68.85 ml/min flow rates in HH102 and 68.85 ml/min in HH97. Effective rates
of 100% result in TH-ABT’s (<35℃) evident at the LCX outlets.

Preferred candidates for LAD and LCX heart cooling are represented by the bars
that reached 100% TH-ABT effective levels in Figures 8.5 and 8.6. This means that each
bar reaching 100% effective levels had ABT’s less than 35℃ exiting the LAD and LCX
mother branch outlets. Cooling effectiveness is determined by dividing the length of the
LAD that reached ABTs <35°C divided by the total length of the LAD. For some
patients, increasing the flow rate seemed to have little effect on adding cooling
effectiveness in each LAD mother vessel. For the remaining patients, we can assume that
49.03 ml/min GuideLiner® flow rate is sufficient to use in TH intracoronary procedures
in lieu of 68.85 ml/min. The SA:V ratios are illustrated from left to right in increasing
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order (Fig. 8.5), which resulted in no identifiable trends that link cooling effectiveness to
increased values of SA:V for the entire LAD network.
A slight trend between high SA:V ratios in most of the patient-specific LCX
models is apparent compared to low SA:V ratios (Fig. 8.6). Cooling effectiveness in the
LCX appeared to trend differently than the LAD data where increased SA:V ratios in the
LCX tended to lead towards greater cooling effectiveness. Contrarily, the LAD resulted
in no identifiable trends between SA:V ratios and cooling effectiveness. GuideLiner®
flow rates above and including 49.03 ml/min were 33.3% effective at delivering TH-ABT
at the distal LAD outlets, and 25% effective at the LCX outlets.
The remaining 66.7% of LAD candidates that experienced proximal flow rates
greater than 49.03 ml/min were considered bad candidates for heart cooling since their
TH-ABT’s only traveled ≤ 60% into the mother branches, with the exception of one that
travelled 73.08% into the mother branch (Fig. 8.5). Additionally, 75% of LCX candidates
that experienced proximal flow rates greater than 49.03 ml/min were considered bad
candidates for heart cooling since their TH-ABT’s only traveled ≤ 74.8% into the mother
branches, with the exception of one that travelled 88.9% into the mother branch (Fig.
8.6).
Decreasing values of 𝜂𝑇𝐶 were compared to the ABT at each LAD and LCX
artery mother vessel outlet. ABT data for all three GuideLiner® flow rates were plotted
vs decreasing 𝜂𝑇𝐶 and the seven preferred heart cooling candidates were isolated using a
dashed box (Fig. 8.7).
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ABT (°C) at Mother Vessel Outlet

ABT at Mother Vessel Outlet for each GuideLiner® Flow Rate
38
37
36
35
34
33
32
31
30
HH102 HH88 HH102 HH97 HH88 HH259 HH178 HH55 HH178 HH97 HH55 HH259
LAD
LAD
LCX
LCX
LCX
LCX
LAD
LCX
LCX
LAD
LAD
LAD

Decreasing 𝜂𝑇𝐶
68.85 mL/min

49.03 mL/min

29.2 mL/min

Figure 8.7. Mother vessel outlet ABT data plots for each GuideLiner® flow rate vs
decreasing 𝜂𝑇𝐶 values. Seven recommended heart cooling candidates are isolated in the
dashed box which are segregated by TH-ABTs <35°C (horizontal line) and 𝜂𝑇𝐶 > 97.63%
(vertical line).

TH-ABTs were evident in the remaining seven out of the total thirty-six CFD
simulations at the distal LAD and LCX posterolateral outlets for 49.03 ml/min and 68.85
ml/min flow rates. The associated distance for each ABT value is summarized in Table
8.1.

Table 8.1
GuideLiner® flow rates associated with TH-ABT’s leaving the LAD and LCX outlets.
Location
Flowrate @ 49.03 ml/min
Flowrate @ 68.85 ml/min
Distance to
ABT at
Distance to
ABT @
Outlet (mm) Outlet (℃) Outlet (mm) Outlet (℃)
HH88 LAD
130
34.13
130
32.69
HH97 LCX
----90
34.55
HH102 LAD
80
33.1
80
30.47
HH102 LCX
90
34.34
90
31.54
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TH-ABT in the LAD and LCX mother vessels varied in temperature at the outlet
for each HH model and GuideLiner® flow rate. As shown previously, higher flow rates
tended to yield cooler ABTs along the artery pathway. However, Table 8.1 shows that not
all patients experiencing 68.85 mL/min GuideLiner® flow rates revealed lower ABTs
compared to 49.02 mL/min GuideLiner® low rates. While each patient-specific coronary
artery network is unique to the number of branches, outlets, and artery dimensions it has,
the critical factor to consider is that ABTs vary in each patient’s LAD and LCX artery
regardless of GuideLiner® flow rate.
Summary. In summary, three distinguishable methods were obtained from this
work and used to distinguish between good and bad candidates for localized heart cooling
(Table 8.2).

Table 8.2
Good and bad heart cooling candidates as recommended assuming 68.85 mL/min
proximal GuideLiner® flow rate.
Insight
Number

Good/Bad Candidate Evaluation for Recommended 𝛈𝐓𝐂

1

Number of diverting branches from Recommended Avg. / ST Dev.
mother vessel (Fig. 8.3)
cut-off value
Good Candidate
≤6
4.5 +/- 1.9
Bad Candidate
≥7
6.5 +/- 3.5
2
Number of outlets in artery
network (Fig. 8.4)
Good Candidate
≤ 11
6.4 +/- 2.0
Bad Candidate
≥ 12
13.1 +/- 7.4
3
SA:V · Total Network Length
(Fig. 7.25)
Good Candidate
≤ 700
539.2 +/- 108.8
Bad Candidate
≥ 701
893 +/- 210
Note. Recommended cut-off value for good candidates represents the max value where
𝜂𝑇𝐶 ≥ 97.63%. The cut-off value for bad candidates represents the lowest value where
𝜂𝑇𝐶 ≤ 85.26%. Values 1 and 2 are estimated values determined using linear regression
models and should only be considered in combination with insight number 3.
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While these insights help to provide recommended guidelines for determining
preferred candidates for heart cooling, a few exceptions were identified in bad candidate
hearts where good candidate characteristics were evident. Patient HH259 is a good
example of a bad heart cooling candidate even though it contained LAD and LCX
branches stemming from the mother vessel that fell within preferred candidate ranges
(Table 8.3), and had the largest SA:V ratio out of all six LAD representative heart (RH)
models.

Table 8.3
Good and bad heart cooling candidates with their corresponding number of outlets and
vessel branches stemming from the mother branch.
LAD 𝑀𝑣
LCX 𝑀𝑣
LAD 𝑇𝑛
LCX 𝑇𝑛
Diverting Branches Diverting Branches
Outlets
Outlets
HH55
7
13
14
30
HH88
2
3
7
8
HH97
8
6
10
7
HH102
6
4
11
7
HH178
9
5
14
11
HH259
5
2
12
6
Note. Mother vessel = 𝑀𝑣 and total network = 𝑇𝑛 . Preferred heart cooling candidates are
highlighted. Results represent inlet flow rates greater than and including 49.03 ml/min.

A combination of the three methods described in Table 8.2 for determining which
candidates are suitable for localized intracoronary heart cooling involved determining the
number of branches stemming from the mother branch of interest, the number of outlets
in the LAD and LCX artery networks, and the surface area to volume ratio multiplied by
the total network length for each patient-specific LAD and LCX artery. Implementing
these three methods, as well as employing the appropriate proximal GuideLiner® flow
rates prior to a localized intracoronary heart cooling procedure will help to provide
insight on the potential outcome of cooling effectiveness. The computational work
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described herein provides a foundation to guide cardiovascular interventionist’s use of
therapeutic hypothermia to optimize cooling performance and patient outcomes.
Future work
Geometry. Future work for this study should be focused on attaining additional
heart models from the Visible Heart Lab (VHL) website and additional resources where
higher DICOM image resolutions are available. Since the vasculature is not rigid, future
work should also explore fluid-structure interaction.
Additional heart models. Implementing additional heart models will introduce
more anatomical variations which could help improve the accuracy of our predicted 𝜂𝑇𝐶
to SA:V ⋅ total network length ratios in each mother vessel. Executing a large range of
patient-specific heart models will broaden the scope of this work and will introduce an
extensive collection of patient-specific vascular networks for determining their impact on
localized TH cooling.
Physics. The physics solvers employed in the STAR-CCM+ simulations were
constrained to steady state laminar flow conditions. Each of the mass flow inlet
conditions were performed using constant flow rates that exhibited no pulsatile affects.
Future studies should utilize a pulsatile field function in STAR-CCM+ for both the blood
and GuideLiner® inlet conditions. This would produce temperature distributions that
would accurately resemble pulsatile blood flow conditions in the coronary arteries.
Non-mixed blood properties should be used at the start of each simulation and
normal saline at 0.9% NaCl should be used for the GuideLiner® flow instead of distilled
water. Blood flow behavior would also be improved if unsteady state conditions are
applied to each model so that time dependent hemodynamic conditions and hematocrit
levels are considered [4][75][106][123].
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Extending arterial blood temperature predictions towards tissue predictions.
Vessel wall thickness in future studies should be considered and replicated to extend
arterial blood temperature predictions towards tissue predictions. Each of the patientspecific LAD and LCX models had fixed boundary conditions assuming a rigid no-slip
wall boundary, which should be improved to include wall thicknesses to ultimately
provide a more accurate representation of the temperature distributions in each artery
network.
Validation. Since CFD modeling provides an alternative to experimental
development, CFD simulations must always be scrutinized and compared with
experimental results and published data to validate each model’s credibility [134].
In vivo validation of cooling effectiveness and myocardial salvage. To validate
our patient-specific representative heart (RH) models, future efforts should focus on
patient-specific 3D printed replicas that can be used in in vitro mock loop systems to
validate the predicted CFD average bulk temperatures.
Furthermore, in vivo validations could help validate our cooling effectiveness
levels and methods used to determine good candidates for localized TH cooling.
Localized TH cooling studies performed in swine are also excellent models that should
be used to explore additional cooling methods and outcomes [13].
The methods described in this thesis work are used to identify ideal candidates for
localized heart cooling and can be improved and applied in clinical settings where
patients suffering from SA and STEMI could be recommended as ideal candidates for
localized intracoronary cooling to ultimately enhance myocardial salvage [99][96].
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Appendix A

Simplified explanation of fully developed velocity profile, energy balance, and the
temperature dependent heat source equation

Velocity Profile Equation
For incompressible, fully developed laminar flow in a horizontal circular pipe, the
fluid properties will be assumed constant, and flow will move at a constant velocity along
the axial length of the pipe. Thus, velocity u(r) is represented as a steady parabolic profile
and will remain constant in the direction of flow (Fig. A.1).

Figure A.1. The velocity profile for fully developed laminar flow in a pipe with radius R
and length L. At R = 0 at the centerline, the velocity is maximum, 𝑣𝑚𝑎𝑥 . The velocity
profile is constant with respect to z and 𝜃, the coordinate angle of rotation into the page
[153].

The radial direction has no fluid motion; thus, the velocity is zero everywhere
normal to the direction of flow. Since flow is only varying in the r-direction, flow in the
⃑
𝜕𝑣

𝜃 and z direction is neglected, and velocity 𝜕𝑡 is ignored due to steady state flow.
Presuming there are no forces acting on the fluid, the velocity equation in a pipe
becomes:
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Since the pressure will decrease linearly along the length of a pipe, the pressure
gradient,

𝜕𝑝
𝜕𝑧

, is considered a constant. Integrating equation A.1 with respect to the radius

yields the velocity profile as a function of the pipe radius, where vz is the fluid velocity in
the z-direction. To solve for a finite vz at the center of the pipe (r = 0), the velocity must
be zero at the wall (r = R) to satisfy the no-slip boundary condition. Thus, when r = 0,

𝜕𝑣𝑧
𝜕𝑟

is zero and vz is maximum.
The final velocity profile equation for steady, laminar flow in an axisymmetric
pipe becomes:
1

𝜕𝑝

𝑣𝑧 = 4𝜇 ( 𝜕𝑧 ) (𝑟 2 − 𝑅 2 )

(A.2)

where 𝜇 is the viscosity, R is the radius of the pipe, and the velocity distribution in the
pipe is parabolic at any cross section. A relationship can be obtained between the
𝜕𝑝

pressure gradient, 𝜕𝑧 , and volumetric flow rate, Q, by integrating over a finite differential
area, dA = (2πr)dr, in the pipe. The resulting flowrate, Q, through the pipe becomes the
Hagen-Poiseuille equation [153]:
𝑄=

𝜋𝑅 4 ∆𝑝
8𝜇𝑙

(A.3)

where the volumetric flow rate, Q, is proportional to the radius, R, to the fourth power
and inversely proportional to viscosity, 𝜇.
Energy Balance - Governing Equations
The following derivation is a mathematical model used to predict the temperature
profile of a non-isothermal laminar fluid through a simple pipe with constant wall
temperatures. The derived equation will predict flow through a tubular pipe with constant
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heated walls to determine the pipes outlet temperatures. The energy balance for a horizontal
pipe system with heat and work [154] can be described as,
𝑑

𝑞 − 𝑤 + ∑ 𝐸𝑖𝑛 − ∑ 𝐸𝑜𝑢𝑡 = 𝑑𝑡 (𝐸𝑠𝑦𝑠 )

(A.4)

where q is the convective heat flux from the surface of the pipe into the fluid, w is work,
and 𝐸𝑠𝑦𝑠 is the total energy change in the computational domain of the pipe with respect to
time.
To apply (A.4) to an energy balance for steady-state, laminar fluid flow in a simple
horizontal pipe system with constant wall temperatures, there is no work being done, so w
= 0, and the energy balance becomes an unsteady-state partial differential equation (PDE)
with the form [155]:
𝜕𝐸
𝜕𝑡

=

−𝜕(𝐶𝑝 𝑇𝐴𝐵𝑇 𝑚̇)
𝐴𝑐 ∆𝑍

2

+ ℎ(𝑇𝑤 − 𝑇𝑖𝑛 ) 𝑅

(A.5)

where 𝐶𝑝 is the specific heat, 𝑇𝐴𝐵𝑇 represents the difference in average bulk temperature
(ABT) of the fluid across the length of the pipe, 𝑚̇ is the mass flow rate, 𝐴𝑐 is the crosssectional area of the pipe, ℎ is the heat transfer coefficient, 𝑇𝑤 is the temperature of the
wall, and 𝑇𝑖𝑛 is the ABT entering the pipe.
Assuming steady-state,

𝜕𝐸
𝜕𝑡

in equation (A.5) goes to zero, and if we combine like

terms, integrate with respect to temperature from 𝑇𝑖𝑛 to 𝑇𝑂𝑢𝑡 across the length of the pipe,
and rearrange to solve for 𝑇𝑂𝑢𝑡 , the final analytical equation for the steady-state
temperature profile becomes:
𝑇𝑂𝑢𝑡 = 𝑇𝑤 − (𝑇𝑤 − 𝑇𝑖𝑛 )𝑒

(−

ℎ2𝜋𝑅
𝑧)
𝐶𝑝 𝑚̇

(A.6)

where 𝑇𝑂𝑢𝑡 is the ABT at the outlet of the pipe, R is the radius, and z is the length of the
pipe.
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Temperature dependent heat source equation
A common model used to determine the temperature difference between the surface
of a pipe and its internal fluid flow is the temperature dependent heat source equation [156]:
𝑄𝑐 = 𝑚̇𝑐 𝐶𝑝,𝑐 ∆𝑇𝑐

(A.7)

where 𝑄𝑐 is the cooling capacity and is dependent on the mass flow rate, 𝑚̇𝑐 , the specific
heat, 𝐶𝑝,𝑐 , and the difference between the pipe surface temperature and the outlet
temperature, ∆𝑇𝑐 .
In Eq. (A.7), the heat flux, 𝑄𝑐 , can also be described as the heat conduction rate, 𝑞̇ , per
unit area, per unit time, and is defined as Fourier’s Law of Cooling [156] for a onedimensional plane:
𝑞̇ = −𝑘

𝛥𝑇𝑤
𝛥𝑥

(A.8)

where −𝑘 is the thermal conductivity representing the heat-flux moving from high to low
temperatures, Δ𝑇𝑤 is the change in temperature between the outer and inner wall, and Δ𝑥
is the thickness of the wall.
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Appendix B

Description of viscosity entered as function of temperature in STAR-CCM+

As discussed in Chapter 2, Equation 2.11, was used to determine the dynamic
1

viscosity as a function of mixed temperature 𝑇𝑚 (℃), shear rate Υ (𝑠 ), and hematocrit
(Hct (%)) for each GuideLiner® flow rate [123].
𝜆

ϕ

µ(Υ, Hct, 𝑇𝑚 ) = (𝑒 Υ+ƞ⋅𝐻𝑐𝑡 )[𝛼 + (1+𝑒 𝛽(𝑇−Є))]

(2.11)

Equation 2.11 was used to solve for dynamic viscosity in each of the thirty-six
CFD simulations. The ABT at each discrete location along the fluid flow path was plotted
vs Eq. 2.11 to yield a non-linear decreasing slope (Fig. B.1).

Dynamic Viscosity (Pa.s)

2.4E-03
2.2E-03
2.0E-03
1.8E-03
1.6E-03
1.4E-03
1.2E-03
9.8E-04
7.8E-04
5.8E-04
27.9

28.9

29.9

30.9

31.9

32.9

33.9

34.9

35.9

36.9

Average Bulk Temperature (°C)
Avg. Bulk Temp. Vs. Dynamic Viscosity

Figure B.1. ABT along the fluid flow path for HH63 LAD vs dynamic viscosity using
Eq. 2.11.

170

A Polynomial in T function was used to replicate the slope of Fig. B.1 to
represent the independent variables (shear rate, hematocrit, and temperature) and the
dependent variable (dynamic viscosity) from Eq. 2.11 and were entered as a function of
temperature in STAR-CCM+ (Fig. B.2).

Figure B.2. Equation 2.11 applied as a Polynomial in T function in STAR-CCM+.

The slope from Figure 2b is an extrapolation of Figure 2a which was entered as a
function in STAR-CCM+ and applied to all thirty-six patient-specific CFD simulations.
A constant viscosity at 32.5°C was for the 28.5 mL/min GuideLiner® flow rate
was plotted with a polynomial in T function against temperature along the fluid flow path
of HH63 LAD (Fig. B.3).
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Temperature (C)
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Catheter Proximal
First
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Inlet
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1
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LAD
Branch Perforator

Location Along LAD Artery Blood Pathway
Constant Viscosity @ 28.5 ml/min using mu @ 32.5 C

Polynomial in T @ 28.5 ml/min

Figure B.3. ABT at discrete locations along HH63 LAD fluid flow path at 29.2 mL/min
GuideLiner® flow rate.

The Polynomial in T data fit the constant viscosity assumption fit fairly well with
very little variation in the trendline from the GuideLiner® inlet to the LAD outlet.
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Appendix C

Extension of the thermal fluid modeling matrix specifications

An extension of the thermal fluid model testing matrix is herein described for
each patient-specific representative heart model. A more comprehensive version of the
specifications are described in detail in the following tables – courtesy of the Atlas of
Human Cardiac Anatomy from the Visible Heart Lab, University of Minnesota.
Figures C.1 – C.4 illustrate an extension of the thermal fluid modeling matrix of
heart histories and specimen demographics. The information from Figure C.1 is freely
available on the Atlas of Human Cardiac Anatomy website (Link:
http://www.vhlab.umn.edu/atlas/).
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Appendix D

Qualitative analysis of how ABT changes along the fluid flow path using simple 3D
tube flow in STAR-CCM+

As illustrated in Chapter 7, ABTs increased along the length of the arteries and
experienced dramatic increases in ABT where vessels branched or artery diameters
significantly reduced in size. For the simple 3D tube case, however, a slight increase in
ABT is evident between the Proximal 8 and Mid 1 planes (Fig. D.1).

31
30.5

ABT (°C)

30
29.5
29
28.5
28
27.5
27
26.5

ABT cross-sectional plane location along 3D tube
Figure D.1. ABT cross-sectional planes along 3D tube for simple pipe flow using 28.5
mL/min GuideLiner® flow rate at 13.33°C.

The sudden increase in slope between the Proximal 8 and Mid 1 cut planes was
due to a 3x gap extension implemented for the remaining Mid cut planes. The extended
gap between cut planes and contour ABT plots along the fluid path of the 3D tube are
illustrated in Fig. D.2.
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Figure D.2. Contour plots of the ABT cross-sectional planes as illustrated in Fig. 3a at
each location along the length of the simple 3D tube. Mixing between the chilled saline
(blue) and blood (red) increases as flow continues down the length of the tube, with the
most mixing occurring towards the outlet, as seen in the Mid 7 (M7) contour plot.

Figure D.2 illustrates the mixing effect between GuideLiner® and blood flow by
considering the temperature contours at each cross sectional plane within the tube. To
visualize the flow field and temperature distribution within each artery vessel, each fluid
is colored with respect to temperature, with chilled distilled water (blue) and blood (red).
It is evident that mixing and rewarming occurs downstream in the tube since the majority
of the contour color falls within yellow and green temperatures (25-33°C), which is much
higher than the temperature at the GuideLiner® inlet (13.33°C). Since this method was
applied to each RH model, custom cross-sectional planes were created along each fluid
flow path so that temperature distributions could be investigated for each patient-specific
vascular network.
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